Generated by All in One SEO v4.9.10, this is an llms.txt file, used by LLMs to index the site.

# AIDS and Cancer Specimen Resource

HIV Malignancy Specimens for Research at No Charge

## Sitemaps

- [XML Sitemap](https://acsr1.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [AACR 2021 Annual Meeting Meeting Registration is OPEN](https://acsr1.com/aacr-2021annual-meeting-meeting-registration-is-open/) - The AACR Annual Meeting 2021 will be presented over two separate weeks: April 10-15, 2021May 17-21, 2021 Registration includes access to both weeks and on-demand access to all sessions through June 21. Early Registration deadline: January 15.
- [Funding Opportunity Announcement: Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)](https://acsr1.com/funding-opportunity-announcement-cancer-prevention-detection-diagnosis-and-treatment-technologies-for-global-health-u01-clinical-trial-optional/) - Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) This Funding Opportunity Announcement (FOA) supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of
- [National HIV Testing Day June 27](https://acsr1.com/national-hiv-testing-day-june-27-2/) - National HIV Testing Day (NHTD) was first observed on June 27, 1995. This is a day to encourage people to get tested for HIV, know their status, and get linked to care and treatment. Take the Test & Take the Next Step! #HIVTESTINGDAY
- [HIV Testing is Self Care on National HIV Testing day](https://acsr1.com/national-hiv-testing-day/) - June 27 is National HIV Testing Day (NHTD). On this day, the ACSR stands by partners, clinicians, researchers, organizations across the health care spectrum to raise awareness about the importance of HIV testing & early diagnosis of HIV. Let’s stop HIV together.
- [New Funding Opportunity Centers for AIDS Research (CFAR)](https://acsr1.com/new-funding-opportunity-centers-for-aids-research-cfar/) - Funding Opportunity Announcement (FOA) Number PAR-20-106 The purpose of this Funding Opportunity Announcement (FOA) PAR-20-106 is to invite applications for the Centers for AIDS Research (CFAR) program-to provide administrative and shared research support to enhance HIV/AIDS research. CFARs provide core facilities, expertise, resources, and services not readily obtained otherwise through more traditional funding mechanisms. The
- [Notice of Intent to Publish a Funding Opportunity Announcement KSHV R01](https://acsr1.com/notice-of-intent-to-publish-a-funding-opportunity-announcement-kshv-r01/) - Notice Number NOT-CA-20-098 Notice of Intent to Publish a Funding Opportunity Announcement for Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) The National Cancer Institute (NCI) intends to promote a reissuance of an initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications to advance our understanding of the
- [FUNDING OPPORTUNITY ANNOUNCEMENT: Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV](https://acsr1.com/funding-opportunity-announcement-understanding-oral-hpv-infection-in-plh/) - These National Institutes of Health (NIH) Funding Opportunity Announcements (FOA) solicit research to better understand the epidemiology & biology of oral human papillomavirus (HPV) infection, its acquisition and persistence, in people living with HIV and elucidate the initial mechanisms related to HPV-associated oral and oropharyngeal cancers and warts in the context of HIV. The FOA
- [New NCI FOA U.S. and Low- and Middle-Income Country HIV-Associated Malignancy Research Centers](https://acsr1.com/new-nci-foa-rfa-ca-22-001/) - RFA-CA-22-001, U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional) has been published. This is a reissuance of RFA-CA-20-001. The purpose of this Funding Opportunity Announcement (FOA) is to support research on human immunodeficiency virus (HIV)-associated cancers in low- and middle-income countries (LMICs) through the formation of collaborative partnerships between investigators
- [International Conference on EBV & KSHV 2018](https://acsr1.com/international-conference-on-ebv-kshv-2018/) - 2018 International Conference on EBV and KSHV The EBV/KSHV Meeting will take place July 28 - August 1, 2018, at the Memorial Union on the University of Wisconsin-Madison campus. The overlapping DNA Tumor Viruses Meeting will be held July 31 - August 4th, 2018. Please stop by the ACSR table during the poster session on Sunday,
- [Pre-Application Webinar: The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer](https://acsr1.com/pre-application-webinar-the-confluence-of-cancer-stigma-and-hiv-stigma-in-plwh-diagnosed-with-cancer/) - From the National Cancer Institute https://cancercontrol.cancer.gov/brp/events/pre-application-webinar-the-confluence-of-cancer-stigma-and-hiv-stigma-in-hiv-positive-individuals-diagnosed-with-cancer?cid=eb_govdel Pre-Application Webinar: The Confluence of Cancer Stigma and HIV Stigma in HIV-Positive Individuals Diagnosed with Cancer Date: Wednesday, September 25, 2024, 1:00 p.m.–2:00 p.m. ETRegistration Description: This webinar will provide information about RFA-CA-25-011, “The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional)”
- [22nd International Workshop on Kaposi Sarcoma Herpesvirus (KSHV) & Related Agents](https://acsr1.com/22nd-international-workshop-on-kaposi-sarcoma-herpesvirus-kshv-related-agents/) - KSHV and Related Agents 2019 The 22nd International Conference on Kaposi’s sarcoma-associated herpesvirus and Related Agents is the 25th Anniversary of the virus’s discovery. This meeting will be heald June 30 - July 3, 2019, in New York City. (READ MORE)
- [13th Annual ACTHIV Conference](https://acsr1.com/13th-annual-acthiv-conference/) - ACTHIV 2019 The American Conference for the Treatment of HIV will be held April 11 - 13, 2019, at the Hilton Miami Downtown Hotel in Miami, Florida. (READ MORE)
- [AIDS Malignancy Consortium Fellowship Program](https://acsr1.com/amc-fellowship-program/) - AMC Fellowship Program The fellowship program was established to encourage and foster the development of new and junior clinical investigators at our domestic and international sites to pursue careers in clinical research trials in HIV associated malignancies within the context of the AMC. These fellowships are designed to allow the fellow to participate in the
- [AACR Virtual Annual Meeting 2020](https://acsr1.com/aacr-virtual-annual-meeting-2020/) - Turning Science into Lifesaving Care The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world.
- [FUNDING OPPORTUNITY ANNOUNCEMENT: Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional)](https://acsr1.com/rfa-ca-20-046/) - FOA Number: RFA-CA-20-046 Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to advance our understanding of: the modes of transmission of Kaposi sarcoma-associated herpesvirus (KSHV), also called human herpesvirus-8 (HHV-8); the biology of the initial steps of infection;
- [The 23rd International Conference on Kaposi’s Sarcoma Herpesvirus (KSHV) and Related Agents Virtual Meeting](https://acsr1.com/kshv-2021/) - The 23rd International Conference on Kaposi’s Sarcoma Herpesvirus (KSHV) and Related Agents Virtual Meeting will take place from June 21 – 24, 2021. Abstract Submission Deadline is April 12, 2021. Visit the conference website for more information!
- [Announcing the ACSR's new url and email address!](https://acsr1.com/url/) - We've got a new url and email address! VISIT OFTEN! https://acsr1.com/ email: contact@acsr1.com
- [ACSR Investigator awarded P30 Cancer Center Support Grant](https://acsr1.com/acsr-investigator-awarded-p30-cancer-center-support-grant/) - Join us in congratulating Dr. Alanna Maguire, recipient of a P30 Cancer Center Support Grant to Stimulate Research in HIV/AIDS Cancer Research Projects. We wish Dr. Maguire the best on her project entitled “Molecular Characterization of HIV Associated Diffuse Large B-Cell Lymphoma”.
- [Notice of Special Interest: Funding for Research on SARS-CoV-2 and COVID-19](https://acsr1.com/notice-of-special-interest-covid_19/) - Notice of Special Interest: Funding for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Notice Number: NOT-AI-20-034 Key DatesRelease Date: March 25, 2020First Available Due Date: March 25, 2020Expiration Date: March 25, 2021 Related AnnouncementsNOT-AI-20-040PA-20-135; Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) Issued byNational Institute of Allergy
- [2018 United States Conference on AIDS](https://acsr1.com/2018-united-states-conference-on-aids/) - 2018 USCA The 2018 United States Conference on AIDS (USCA) will be held September 6-9 at the Hyatt Regency in Orlando, FL. (READ MORE)
- [22nd International AIDS Conference](https://acsr1.com/22nd-international-aids-conference/) - AIDS 2018 The 22nd International AIDS Conference will be hosted in Amsterdam, Netherlands from July 23-27, 2018. (READ MORE)
- [10th IAS Conference on HIV Science](https://acsr1.com/10th-ias-conference-on-hiv-science/) - IAS 2019 The 10th IAS Conference on HIV Science will take place on 21-24 July 2019, in Mexico City, Mexico (READ MORE)
- [Case Study Using ACSR Specimens: NanoString Technologies, Inc. Webinar](https://acsr1.com/case-study-using-acsr-specimens-nanostring-technologies-inc-webinar/) - Congratulations to the ACSR's Dr. Alanna Maguire whose work was featured in a NanoString Technologies, Inc. webinar showcasing how Rosalind® was used to identify novel markers and potential therapeutic targets in HIV infected individuals. Register for an encore of the webinar by clicking on the link below! Nanostring DLBCL Webinar, February 2, 2021 Title: A ROSALIND®
- [One Less Worry - Implementing the HPV Vaccine for All](https://acsr1.com/implementing-the-hpv-vaccine-for-all/) - INTERNATIONAL HPV AWARENESS DAY04 MARCH 2022 HPV is the human papillomavirus. Almost all of us will have HPV at some point and while for most of us it isn't harmful, HPV is linked to several kinds of cancer. Educating ourselves and others about HPV and cancer is the first step to reducing our risk. Find
- [New to Journal of Visualized Experiments (JoVE), ACSR TMA Construction](https://acsr1.com/tma-on-jove/) - The ACSR's recent publication in the Journal of Visualized Experiments (JoVE) entitled “Manual Construction of a Tissue Microarray using the Tape Method and a Handheld Microarrayer” is now PubMed indexed and its corresponding experimental methods video available for viewing on JoVE. This article and video is a "How-to" outlining TMA construction using the fully manual
- [New in JAMA: Expanding Efforts and Support to Respond to HIV and COVID-19](https://acsr1.com/expanding-efforts-and-support-to-respond-to-hiv-and-covid-19/) - In this opinion piece featured in JAMA, Lawrence Corey, Russell Corbett-Detig, Chris Beyrer write about the exceedingly harmful effects that SARS-CoV-2 variants and HIV has had on the other. The recent history of these intersecting viruses has highlighted the need for more equitable healthcare around the globe. Expansion of financial resources, increased care services, surveillance,
- [Registration Now! Global Oncology Symposium on Oncogenic Viruses](https://acsr1.com/coh-global-oncology-symposium-2023/) - City of Hope’s, in person and virtual, Global Oncology Symposium on Oncogenic Viruses will take place Fri, Oct 27, 8 a.m.-3:30 p.m. PDT. The symposium promises to cover a comprehensive perspective including cancer control in low and middle income countries to molecular mechanisms and therapies. This Symposium will showcase four sessions of presentations from our
- [How Cancer Research Led to AIDS Breakthroughs](https://acsr1.com/how-cancer-research-led-to-aids-breakthroughs/) - Did you know some of the earliest AIDS patient care & research was performed by National Cancer Institute scientists & external researchers funded by NCI? Read how cancer research led to AIDS breakthroughs and learn about how the Office of HIV and AIDS Malignancy (OHAM) was established. https://cancer.gov/.../how-cancer-research-led-to-aids...… Office of HIV and AIDS Malignancy (OHAM) facilitates
- [Earth Day 2023, Invest In Our Planet](https://acsr1.com/earth-day-2023-invest-in-our-planet/) - The National Institutes of Health Climate Change and Health Initiative has been bringing together experts, including those from the National Cancer Institute (NCI), to study the health effects of climate change and cancer and develop strategies for global health AND invest in our planet. The ACSR is committed to celebrating Earth Day everyday. When our
- [59th American Society of Hematology Annual Meeting & Exposition](https://acsr1.com/59th-american-society-of-hematology-annual-meeting-exposition/) - 59th ASH Annual Meeting Come Visit Us at ASH 2017 from December 9-12 held at the Georgia World Congress Center Booth #1740 (READ MORE)
- [Apply NOW: Postdoctoral Fellowship Opportunity Burkitt Lymphoma Research](https://acsr1.com/emblem-burkitt-lymphoma-research/) - A specific opportunity is available to work on projects related to Burkitt lymphoma (BL) in the context of research on the Epidemiology of Burkitt Lymphoma (BL) in East African Children and Minors (EMBLEM) study. Under the mentorship of Sam M. Mbulaiteye, M.D., senior investigator, Infections and Immunoepidemiology Branch (IIB) of the National Cancer Institute’s Division of
- [Apply now: Cancer Moonshot Scholars program](https://acsr1.com/apply-now-cancer-moonshot-scholars-program/) - From Cancer Moonshot Scholars program, originally published by the National Cancer Institute "The Cancer Moonshot Scholars program is designed to advance cancer science while also diversifying the pool of researchers and the approaches to cancer research that NCI funds. The program seeks to diversify the NCI R01 portfolio by enhancing the number of applications
- [LRF elects ACSR's Lisa Rimsza to their Scientific Advisory Board](https://acsr1.com/lrf-elects-acsrs-lisa-rimsza-to-their-scientific-advisory-board/) - Congratulations to ACSR Technology Core Principal Investigator, Dr. Lisa Rimsza, one of three newly elected Lymphoma Research Foundation Scientific Advisory Board Members! Meet the LRF Scientific Advisory Board Members here: https://lymphoma.org/newsarchive/meet-the-newly-elected-lrf-scientific-advisory-board-members/
- [ACSR PLOS ONE Publication](https://acsr1.com/acsr-plos-one-publication/) - Biospecimen Science Study of ACSR Archival FFPE Tissues Yakovleva A, Plieskatt JL, Jensen S, Humeida R, Lang J, et al. (2017) Fit for genomic and proteomic purposes: Sampling the fitness of nucleic acid and protein derivatives from formalin fixed paraffin embedded tissue. PLOS ONE 12(7): e0181756. (READ MORE)
- [Celebrating Women and Girls in Science Day, February 11](https://acsr1.com/celebrating-women-and-girls-in-science-day-february-11/) - Today, February 11th, we recognize the role of women and girls in science, not only as beneficiaries, but also as agents of change, including in view of accelerating progress towards the achievement of SDG 6 (Clean Water and Sanitation), the 7th International Day of Women and Girls in Science Assembly theme is: “Equity, Diversity, and
- [ACSR YIPA, Arti Vashist, presenting at NanoFlorida](https://acsr1.com/acsr-yipa-arti-vashist-presenting-at-nanoflorida/) - The ACSR is proud to celebrate Arti Vashist, Fall 2021 YIPA recipient! Dr. Vashist will be presenting her poster abstract entitled: "Development of vegetable oil-based Micro/nanogels as versatile system for anti-HIV applications" at NanoFlorida 2023. NanoFlorida is an annual nanoscience technology symposium held at different Florida institutions of higher learning. As a student-led conference, NanoFlorida
- [Congratulations, Dr. Monica Bertagnolli, NIH Director](https://acsr1.com/congratulations-dr-monica-bertagnolli-nih-director/) - The ACSR congratulates Dr. Monica Bertagnolli as she takes the helm as the 17th NIH Director! She is the first surgeon and the second woman to hold the position. Nominated by President Biden, Dr. Bertagnolli was confirmed on a bipartisan basis by the U.S. Senate on November 7. She transitioned from her role as the
- [Statement on the departure of National Cancer Institute Director Dr. W. Kimryn Rathmell](https://acsr1.com/statement-on-the-departure-of-national-cancer-institute-director-dr-w-kimryn-rathmell/) - As customary with transition for presidential appointees, W. Kimryn Rathmell, M.D., Ph.D., announced her decision to step down as the 17th Director of the National Cancer Institute (NCI). Dr. Rathmell assumed the role on December 18, 2023. During her brief tenure. Dr. Rathmell has been a champion for women's health, health equity, and research equity
- [SEMINAR!  Introduction of HPV Testing and HPV Self-Collection in Argentina: Results From the Evidence](https://acsr1.com/seminar-hpv-testing-hpv-self-collection-in-argentina/) - Calling all colleagues conducting research on the Human papilloma virus (HPV! The September 14th NCI Global Cancer Research and Control Seminar will feature Dr. Silvina Arrossi, a senior researcher at the National Council for Scientific and Technological Research (CONICET) and at the Centro de Estudios de Estado y Sociedad (CEDES), Argentina and her work with
- [Meet Our Spring 2021 Young Investigator Pilot Award Recipients!](https://acsr1.com/2021-spring-pilot-awardees/) - Young Investigator Pilot Award Spring 2021 Awardees The ACSR is committed to supporting the next generation of HIV researchers by offering a grant award program for early-stage investigators interested in conducting HIV-related research, especially for malignancies. The goal is to encourage novel and rigorous scientific research projects that utilize biospecimens and data in the ACSR
- [World Cancer Research Day, September 24, 2021](https://acsr1.com/world-cancer-research-day-september-24-2021/) - Have you signed the World Declaration for Cancer Research? On #WorldCancerResearchDay, we invite you to join us in the movement towards a tomorrow without cancer.
- [Remembering Enrique Mesri, ACSR colleague, KSHV researcher](https://acsr1.com/in-memoriam-enrique-mesri/) - It is with great sadness that we share the news of the passing of our respected colleague, Enrique Mesri. Dr. Mesri was a passionate researcher, charismatic leader, consummate mentor, and friend to many. Dr. Mesri spent his career playing a critical role in shaping HIV/AIDS malignancy research and was considered an international authority in Kaposi’s
- [NCI CGH Director Satish Gopal ASCO 2024 Humanitarian Award](https://acsr1.com/nci-cgh-director-satish-gopal-asco-2024-humanitarian-award/) - Congratulations to National Cancer Institute (NCI) Center for Global Health (CGH) Director, Satish Gopal, recipient of American Society of Clinical Oncology (ASCO) 2024 Humanitarian Award, recognizing his outstanding leadership in global oncology, global health and commitment to training and mentorship! Dr. Gopal was appointed Director of the Center for Global Health at the National Cancer
- [Monica M. Bertagnolli, M.D., ends her tenure as NIH director](https://acsr1.com/monica-m-bertagnolli-m-d-ends-her-tenure-as-nih-director/) - On January 17, 2025, Dr. Monica M Bertagnolli will end her tenure as the 17th director of the National Institutes of Health (NIH). Dr. Bertagnolli took office on Nov. 9, 2023. We are grateful for her leadership, guidance and her dedication to endorsing affordable and equitable health care around the globe. We wish her the
- [Join ACSR's Alanna Maguire, JoVE January Webinar](https://acsr1.com/join-acsrs-alanna-maguire-jove-january-webinar/) - The ACSR is delighted to extend an upcoming learning opportunity courtesy of the January Journal of Visualized Experiments (JoVE) webinar "Enhancing Tumor Content: Macrodissection Method," to learn a relatively quick and simple method of Macrodissection hosted by ACSR's own Dr. Alanna Maguire, Assoc. Consultant & Asst. Prof. of Cancer Biology at Mayo Clinic Arizona. If
- [Joint International Symposium on EBV & KSHV & Related Agents & Diseases](https://acsr1.com/joint-international-symposium-on-ebv-kshv-related-agents-diseases/) - Join the world’s EBV and KSHV experts at the upcoming 3rd Joint International Symposium on EBV & KSHV & Related Agents & Diseases: June 29-July 3, 2024 Boston, USA. The welcome reception, meetings and poster sessions will be held at the Hilton Boston Park Plaza in Boston Back Bay area. Abstract submission deadline has been
- [Save the date! UPMC Viral Oncology Symposium](https://acsr1.com/viral-cancers-and-community-outreach-and-engagement-symposium/) - For more information contact: Dr. Shou-Jiang (SJ) Gao at: gaos8@upmc.eduGreg Benzy at benzyg@upmc.edu
- [CANCER DISCOVERY VIRTUAL SYMPOSIUM 2023: REDUCING THE GLOBAL CANCER BURDEN](https://acsr1.com/cancer-discovery-virtual-symposium-2023-reducing-the-global-cancer-burden/) - From MyAACR CANCER DISCOVERY VIRTUAL SYMPOSIUM 2023: REDUCING THE GLOBAL CANCER BURDEN Date/Time: September 26, 2023, 2:30 p.m. to 4:30 p.m.Location: Virtual We are at a pivotal moment in the fight against cancer. National and international efforts are coalescing around calls to action aimed at dramatically decreasing death from cancer in the coming decades.
- [NIH, USHHS honor Drs. Elaine Jaffe, Robert Yarchoan, and Louis Staudt](https://acsr1.com/nih-ushhs-honor-drs-jaffe-yarchoan-staudt/) - Drs. Elaine Jaffe, Louis Staudt and Robert Yarchoan at The National Institutes of Health recipients of Departmental Awards from the U.S. Department of Health and Human Services (HHS) for their groundbreaking research leading to major advances in healthcare and science. This Fall, three scientists at The National Institutes of Health received Departmental Awards from the U.S. Department of Health and Human Services
- [Tackling cancer globally requires research commitments in LMICs- S. Gopal](https://acsr1.com/tackling-cancer-globally-requires-research-commitments-in-lmics-s-gopal/) - Read "Tackling cancer globally requires research commitments in LMICs", the latest Worldview Editorial in Nature written by Dr. Satish Gopal, Director of the National Cancer Institute's Center for Global Health. The reinvigoration of President Biden's Cancer Moonshot initiative reaffirms the importance of supporting global cancer research and promoing health equity especially in low and middle
- [New funding! All of Us commits up to $2 million to fund 20 awards](https://acsr1.com/new-funding-all-of-us-commits-up-to-2-million-to-fund-20-awards/) - AoU-NOSI-fact-sheet_final-1 The NIH Office of AIDS Research (OAR) is working with All of Us Research Program to advance precision medicine All of Us to award up to $2 million in FY22 to support projects funded by NIH partners, including a commitment of $500,000 from the NIH OAR The NIH OAR is one of
- [NIH World AIDS Day Observance, December 1, 2020](https://acsr1.com/nih-world-aids-day-observance-2020/) - Please join the Office of AIDS Research (OAR) for the NIH World AIDS Day Observance Tuesday, December 1, 2020, from 11:00 a.m. to 12:30 p.m. EST. This virtual event is open to the public and will be videocast live. The NIH theme for World AIDS Day 2020 is Science and Community: Working Together to Prepare
- [R01 Research Project Grant](https://acsr1.com/r01-research-project-grant/) - HIV/AIDS AND TUMOR NICHE The purpose of this Funding Opportunity Announcement (FOA) is to advance our understanding of the role of the tumor niche or microenvironment in the risks, development, progression, diagnosis, and treatment of cancer observed in individuals with an underlying HIV infection or Acquired Immune Deficiency Syndrome (AIDS). Applications are due by 5PM
- [A Single Dose Of HPV Vaccine May Provide Adequate Protection](https://acsr1.com/a-single-dose-of-hpv-vaccine-may-provide-adequate-protection/) - NEW from the Frederick National Laboratory for Cancer Research, operated by Leidos Biomedical Research, Inc. for the National Cancer Institute. Recent research adds to growing evidence that a single dose of human papillomavirus (HPV) vaccine is highly effective in protecting young women against cervical infection with cancer-causing HPV types. Read about the research, which involved
- [16th International Conference on Malignancies in HIV/AIDS](https://acsr1.com/16th-international-conference-on-malignancies-in-hivaids/) - 16th ICMH Conference This meeting is presented by the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services will take place October 23-24, 2017, at the Lister Hill Center Auditorium on the campus of the National Institutes of Health in Bethesda, Maryland. Please stop
- [Conference on Retroviruses and Opportunistic Infections (CROI) 2020](https://acsr1.com/conference-on-retroviruses-and-opportunistic-infections-croi/) - CROI 2020 The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI 2020 will be held from March 8 to March 11, 2020, at
- ["Enhanced DNA repair and genomic stability identify a novel HIV-related diffuse large B-cell lymphoma signature"](https://acsr1.com/enhanced-dna-repair-and-genomic-stability-identify-a-novel-hiv-related-diffuse-large-b-cell-lymphoma-signature/) - Using ACSR samples, A. Maguire et al. published their report on “Enhanced DNA repair and genomic stability identify a novel HIV-related diffuse large B-cell lymphoma signature” (Int J Cancer. 2019 Dec 1;145(11):3078-3088). Diffuse large B cell lymphoma (DLBCL) is an AIDS-defining illness, and also follows a more aggressive clinical course and frequently presents at advanced
- [Analyses of samples from the ACSR's African Collections show intriguing new findings](https://acsr1.com/analyses-of-samples-from-the-acsrs-african-collections-show-intriguing-new-findings/) - With support and funding awarded through the ACSR's Young Investigator Pilot Award, analyses of samples from the ACSR's African Collections show intriguing new findings that IgE-driven atopic inflammation may contribute to Kaposi Sarcoma pathogenesis. Read more from ACSR YIPA Awardee and Senior Author, Christine King in The Journal of Infectious Diseases, jiaa340, https://doi.org/10.1093/infdis/jiaa340
- [OPEN NOW! Conference on Retroviruses and Opportunistic Infections (CROI) Feb 12-16, 2022](https://acsr1.com/conference-on-retroviruses-2022/) - The Conference on Retroviruses and Opportunistic Infections (CROI) will be held on February 12-16, 2022. CROI 2022 is currently planned to include both virtual and in-person participation, with the in-person portion hosted in Denver, Colorado, USA. The Conference on Retroviruses and Opportunistic Infections (CROI) is the preeminent HIV research meeting in the world and attracts
- [REQUEST FOR APPLICATIONS: AIDS and Cancer Specimen Resource (ACSR)/AIDS Malignancy Consortium (AMC) Latin American Regional Biospecimen Repository](https://acsr1.com/request-for-applications-aids-and-cancer-specimen-resource-acsr-aids-malignancy-consortium-amc-latin-american-regional-biospecimen-repository/) - • Letter of Intent required by December 30, 2020• Proposals must be submitted via e-mail in PDF or MS Word by 5 PM EST, Friday, January 29, 2021 to ssilver@gwu.edu. The AIDS Cancer Specimen Resource (ACSR) and the AIDS Malignancy Consortium (AMC), are pleased to announce a request for applications (RFA) to establish an ACSR/AMC
- [Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings](https://acsr1.com/nosi-pragmatic-trials-in-low-resource-settings/) - From Notice of Special Interest (NOSI): Pragmatic Trials in Low Resource Settings NOT-CA-23-078 NCI encourages applications for pragmatic clinical trials to generate evidence that directly informs decision-making among patients, providers, health systems, communities, and policy makers in LMICs with the goal of improving efficiency, quality, and access for cancer care in resource-constrained settings. The proposed
- [ACSR JAMA Oncology Abstract](https://acsr1.com/acsr-jama-oncology-abstract/) - Biospecimen Science Using ACSR Tissue Microarrays (TMAs) Yanik EL, Kaunitz GJ, Cottrell TR, Succaria F, McMiller TL, Ascierto ML, Esandrio J, Xu H, Ogurtsova A, Cornish T, Lipson EJ, Topalian SL, Engels EA, Taube JM. Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma Implications for Immunotherapy. JAMA Oncol. 2017 Jul 1;3(7):974-978. doi:
- [GROUNDBREAKING RESEARCH USING ACSR SPECIMENS! Insertional activation of STAT3 and LCK by HIV-1 proviruses in T cell lymphoma](https://acsr1.com/groundbreaking-research-using-acsr-specimens-insertional-activation-of-stat3-and-lck-by-hiv-1-proviruses-in-t-cell-lymphoma/) - The ACSR celebrates Dr. John Mellors, et al, for their recent publication in Science and their groundbreaking research showing the important role of HIV provirus integration in the development of T-Cell Lymphoma using specimens from the ACSR! Read the full article here: HIV-Lymphoma-Sci-Adv-2021
- [Notice of Special Interest (NOSI): Research on HIV-associated Malignancies](https://acsr1.com/nosi-hiv-associated-malignancy-research-not-ca-23-070/) - Through this Notice of Special Interest (NOSI), NOT-CA-23-070 the National Cancer Institute (NCI) is a continuation of NOT-CA-20-022, "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers, which expired on January 8, 2023 , and is entitled, “Research on HIV-associated malignancies ” to reflect the most recent Office of AIDS Research priority guidelines for R21 and R01
- [New Funding: Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health](https://acsr1.com/cancer-prevention-detection-diagnosis-and-treatment-technologies-for-global-health/) - From RFA-CA-24-005 This Notice of Funding Opportunity (NOFO) supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the NOFO solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost technologies for preventing, detecting, diagnosing, and/or treating cancers in
- [Registration and Abstracts NOW OPEN: 19th ICMH, October 24-25, 2024](https://acsr1.com/registration-and-abstracts-now-open-19th-icmh-october-24-25-2024/) - This meeting is presented by the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services will take place October 24, 25, at the Natcher Conference Center on the campus of the National Institutes of Health in Bethesda, Maryland. Registration is now open and abstract submissions close
- [NCI Human Tumor Atlas Network (HTAN) Meeting - Jun. 12-13](https://acsr1.com/nci-human-tumor-atlas-network-htan-meeting-jun-12-13/) - Memo From the National Cancer Institute
- [Submit Your Algorithm or Tool to Test Cancer Preventive and Screening Interventions](https://acsr1.com/submit-your-algorithm-or-tool-to-test-cancer-preventive-and-screening-interventions/) - NCI Data Science Funding Opportunity
- ['Finding HIV’s ‘Sweet Spot’ NEW from the NIH Director's Blog](https://acsr1.com/finding-hivs-sweet-spot-new-from-the-nih-directors-blog/) - New from Dr. Lawrence Tablak, NIH Director, a hopeful post describing recent work that may move us a step closer to eliminating latent HIV infection and ultimately finding a cure to end the HIV epidemic. The post features NIH-funded work from a team led by Nadia Roan, Gladstone Institutes, San Francisco and Mohamed Abdel-Mohsen, The
- [NEW Application Date! NCI's Early Investigator Advancement Program (EIAP)](https://acsr1.com/new-application-date-ncis-early-investigator-advancement-program-eiap/) - With the support of the Equity Council, NCI launched EIAP in late 2021 to facilitate the advancement of scientists from diverse backgrounds to become independent investigators. The cancer research enterprise needs a continuous flow of talent through the research career pipeline to thrive. One critical juncture is the transition from junior investigator to independent investigator.
- [Funding Opportunity: Clinical Sites for the HIV/Cervical Cancer Prevention "CASCADE"](https://acsr1.com/funding-opportunity-clinical-sites-for-the-hiv-cervical-cancer-prevention-cascade/) - Through this Funding Opportunity Announcement (FOA) RFA-CA-22-051, the National Cancer Institute (NCI) solicits applications from institutions/organizations to participate as Clinical Sites for the HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network. The ‘CASCADE’ Network will conduct pragmatic clinical trials evaluating the effectiveness of clinically proven interventions to overcome barriers and reduce failures in the cervical cancer
- [Kaposi's Sarcoma-Associated Herpesvirus Transmission RFA](https://acsr1.com/kaposis-sarcoma-associated-herpesvirus-kshv-transmission-rfa/) - KSHV Transmission RFA For more information about this potential funding opportunity, please check out the Office of HIV and AIDS Malignancy's presentation of the FOA Concept to the Board of Scientific Advisors on November 29th, 2017. Application Deadline: August 16, 2018, 5:00 PM (EDT) (READ MORE: R21 and R01)
- [ASCO20 Virtual Education Program](https://acsr1.com/asco20-virtual-education-program-august-8-10-2020-virtual-asco20/) - August 8-10, 2020 Virtual #ASCO20 To register: https://meetings.asco.org/am/registration For more information: #ASCO20
- [20th International Workshop on Kaposi's Sarcoma Herpes Virus and Related Agents](https://acsr1.com/20th-international-workshop-on-kaposis-sarcoma-herpes-virus-kshv-and-related-agents/) - 20th KSHV Workshop 25–28 July 2017 • Berlin, Germany
- [ISBER 2017 Annual Meeting & Exhibitions](https://acsr1.com/isber-2017-annual-meeting-exhibitions/) - ISBER 2017 ANNUAL MEETING Due North: Aligning Biobanking Practice with Evolving Evidence and Innovation.
- [Tenure Eligible/Tenure Track Position in the HIV and AIDS Malignancy Branch (HAMB)](https://acsr1.com/tenure-eligibletenure-track-position-in-the-hiv-and-aids-malignancy-branch-hamb/) - HAMB Tenure Eligible/Tenure Track Investigator The HIV and AIDS Malignancy Branch (HAMB) is seeking a tenure-eligible or tenure-track investigator in the field of HIV–related malignancies or viral oncogenesis. (This posting has been closed).
- [National Cancer Research Month](https://acsr1.com/national-cancer-research-month/) - Take a moment to learn about cancer research (READ MORE).
- [2017 ACSR Young Investigator Pilot Award](https://acsr1.com/2017-acsr-young-investigator-pilot-award/) - 2017 ACSR YIPA Pilot Award Completed 2017 YOUNG INVESTIGATOR PILOT AWARD APPLICATIONS are due by 5pm PDT on February 17, 2017. Applications should be submitted as pdf documents to CODCC@acsr1.com (READ MORE)
- [American Association for Cancer Research Annual Meeting 2017](https://acsr1.com/aacr-annual-meeting-2017/) - AACR Annual Meeting 2017 Come Visit Us at AACR 2017 from April 1-5 held at the Walter E. Washington Convention Center Booth #3321 (READ MORE)
- [Global Oncology Young Investigator Award (YIA)](https://acsr1.com/global-oncology-young-investigator-award-yia/) - Conquer Cancer Foundation (CCF) Funding The Conquer Cancer Foundation (CCF) of ASCO is accepting applications for the inaugural 2018 Global Oncology Young Investigator Award (YIA). The one-year grant provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation of researchers to address global health
- [FUNDING OPPORTUNITY: NCI CRUK Cancer Grand Challenges](https://acsr1.com/funding-opportunity-cancer-grand-challenges/) - The National Cancer Institute (NCI) and Cancer Research UK (CRUK), the world’s leading funders of cancer research, are partnering to fund the Cancer Grand Challenges (CGC) program. Cancer Grand Challenges will fund novel ideas by multidisciplinary research teams from around the world that offer the potential to advance bold cancer research and improve outcomes for
- [EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features](https://acsr1.com/ebv-positive-hiv-associated-diffuse-large-b-cell-lymphomas-are-characterized-by-jak-stat-stat3-pathway-mutations-and-unique-clinicopathologic-features/) - The ACSR is proud to share the latest EBV/DLBCL research from the ACSR's own Lisa Rimsza, Alanna Maguire, and inaugural YIPA Awardee, Joo Song! EBV-positive HIV-associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features. Chapman JR, Bouska AC, Zhang W, Alderuccio JP, Lossos IS, Rimsza LM, Maguire A, Yi S, Chan
- [ACSR in POZ Article July-August 2019](https://acsr1.com/acsr-poz-article/) - Viral Control POZ “Viral Control” Q & A with Dr. Robert Yarchoan, Director of the Office of HIV and AIDS Malignancy at the U.S. National Cancer Institute. Learn more about the ACSR's umbrella program, the Office of HIV and IADS Malignancy (OHAM) in this POZ article: https://www.poz.com/article/viral-control-robert-yarchoan.
- [Results from successful ANCHOR Study in NEJM!](https://acsr1.com/results-from-successful-anchor-study-in-nejm/) - Results from the successful Anal Cancer/HSIL Outcomes Research (ANCHOR) study were published June 16 in the New England Journal of Medicine. This clinical trial of people living with HIV has found that treating anal precancerous growths known as high-grade squamous intraepithelial lesions (HSIL) reduces the chance that anal cancer will develop by 57%. The ANCHOR
- [NEW! The Persistence of HIV Diversity, Transcription, and Nef Protein in Kaposi Sarcoma Tumors during Antiretroviral Therapy](https://acsr1.com/new-the-persistence-of-hiv-diversity-transcription-and-nef-protein-in-ks-tumors-during-art/) - Congratulations ACSR authors & friends on the long awaited "The Persistence of #HIV Diversity, Transcription, and Nef Protein in Kaposi Sarcoma Tumors during Antiretroviral Therapy. https://mdpi.com/1999-4915/14/12/2774 Nolan DJ, Rose R, Zhang R, Leong A, Fogel GB, Scholte LLS, Bethony JM, Bracci P, Lamers SL, McGrath MS. The Persistence of HIV Diversity, Transcription, and Nef Protein
- [Vaccination induces HIV broadly neutralizing antibody precursors in humans](https://acsr1.com/vaccination-induces-hiv-broadly-neutralizing-antibody-precursors-in-humans/) - New off the press by the ACSR's Dr. Jeffrey Bethony and colleagues from George Washington University, Scripps Research, the Fred Hutchinson Cancer Center, the National Institutes of Health and other institutions in the United States and Sweden. An experimental HIV vaccine called eOD-GT8 60mer, had a “favorable safety profile” and has been found to elicit
- [Introducing Our Fall 2021 Young Investigator Pilot Award Recipients!](https://acsr1.com/fall-2021-young-investigator-pilot-award-recipients/) - To learn about our YIPA Awardees click here.
- [LEAD FROM BEHIND: Colorectal Cancer Awareness](https://acsr1.com/lead-from-behind-colorectal-cancer-awareness/) - Video Transcript: Lead from behind! We're on a mission to make colon cancer famous. Why? Because it's preventable. 1 in 3 people who should get checked for colon cancer don’t. Colon cancer screening should begin at age 45 unless you have family history or symptoms, in which case it should be done earlier. Visit LeadFromBehind.org to
- [Cancer Lecture Series, Hosted by the African Cancer Institute @ Stellenbosch University, Aug. 24th 10am ET](https://acsr1.com/cancer-lecture-series-hosted-by-the-african-cancer-institute-stellenbosch-university-aug-24th/)
- [ACSR Embraces Equity on International Women's Day](https://acsr1.com/international-womens-day-2023/) - This week, the ACSR invites you to celebrate the achievements of all women – past and present – reflecting on both how far we have come and where we still need to grow. Together we can forge women’s equality. Collectively we can all work towards the 2023 International Women’s Day theme of “Embrace Equity”. The
- [Today is National Women and Girls HIV/AIDS Awareness Day](https://acsr1.com/national-women-and-girls-hiv-aids-awareness-day/) - Today is National Women and Girls HIV/AIDS Awareness Day, a day to address the impact of HIV on women and girls. When we reduce HIV stigma and promote testing, prevention, and treatment for women, we can help stop HIV together. Together is an evidence-based campaign created in English and Spanish. It aims to empower communities, partners,
- [FUNDING OPPORTUNITY ANNOUNCEMENT:            AIDS and Cancer Specimen Resource (ACSR) Young Investigator Pilot Award (YIPA) for 2021](https://acsr1.com/aids-and-cancer-specimen-resource-yipa2021/) - The U.S. National Cancer Institute (NCI)-funded AIDS and Cancer Specimen Resource (ACSR) is pleased to announce the release of the Young Investigator Pilot Award (YIPA) for 2021. We welcome applications for HIV-related research projects that will use specimens in the ACSR inventory, particularly for HIV malignancies, from early stage investigators who are within 8 years
- [2023 17th Annual ACTHIV Registration NOW OPEN](https://acsr1.com/2023-17th-annual-acthiv-registration/)
- [Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt Lymphoma](https://acsr1.com/plasma-ebv-dna-a-promising-diagnostic-marker-for-endemic-burkitt-lymphoma/) - As 2021 comes to a close, we celebrate some important work published by our colleagues (Ambinder, et al) who dedicate their careers to improving diagnosis, treatment and outcomes for people with cancer, both young and old, not only in the US but globally. In 2022, the ACSR will continue to support researchers with this shared
- [NOW ACCEPTING APPLICATIONS FOR CFAR ADELANTE PROJECTS!](https://acsr1.com/now-accepting-applications-cfar-adelante-project/) - (From the CFAR Adelante RFA: https://cfar-adelante.org/wp-content/uploads/2022/08/Adelante.RFA-CohortV_FINAL-081522.pdf) As confirmed by the National Ending the HIV Epidemic in the U.S. (EHE) Initiative, there has been adearth of culturally responsive research specific to the needs and concerns of Hispanic and/or Latina/x/opeople even as these populations in the United States continue to bear a disproportionate burden of theHIV/AIDS epidemic.
- [SAVE THE DATE: 18th International Conference on Malignancies in HIV AIDS Oct. 24-25, 2022](https://acsr1.com/save-the-date-18th-international-conference-on-malignancies-in-hiv-aids-oct-24-25-2022/) - For the latest information on ICMH 2022 visit: https://www.cancer.gov/about-nci/organization/oham/news-events
- [NOW VIRTUAL 18th Intl Conference On Malignancies In HIV/AIDS 10-24/25](https://acsr1.com/18th-icmh-2022/) - The 18th International Conference on Malignancies in HIV/AIDS (ICMH) previously named the International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) will will be a held as a VIRTUAL conference on October 24-26, 2022 due to the ongoing health concerns surrounding COVID-19. This meeting is presented by the Office of HIV and AIDS
- [Close the Care Gap! February 4 is World Cancer Day](https://acsr1.com/february-4-is-world-cancer-day/)
- [Celebrate Women and Girls in Science Day Feb 11](https://acsr1.com/women-and-girls-in-science-feb-11/) - On February 11th, the ACSR celebrates the role of women and girls in science, not only as beneficiaries, but also as agents of change, including accelerating progress towards the achievement of SDG 6 (Clean Water and Sanitation), SDG 7 (affordable and clean energy), SDG 9 (industry, innovation, and infrastructure), SDG 11 (sustainable cities and communities).
- [Register Now: World Cancer Congress 18-20 October 2022](https://acsr1.com/world-cancer-congress-october-2022/) - The World Cancer Congress is an initiative of the Union for International Cancer Control (UICC) - which was recognized with Membership Engagement Award - and supports the organization's mission: 'to both unite and support the cancer community in its efforts to reduce the global cancer burden, promote greater equity and ensure that cancer control remains
- [World Cancer Day, Februrary 4, 2021](https://acsr1.com/world-cancer-day-februrary-4-2021/) - Everyday, but most especially today, World Cancer Day, the ACSR stands up to cancer. Together, all of our actions matter and the ACSR recommits to supporting our cancer warriors in the effort to find a cure. #iamandiwill https://www.worldcancerday.org/
- [Temporary Extension of Eligibility for the NIH Pathway to Independence Award (K99/R00)](https://acsr1.com/temporary-extension-of-eligibility-for-the-nih-pathway-to-independence-award/) - The National Institutes of Health (NIH) announces an automatic extension until October/November 2025 receipt dates for prospective applicants to the NIH Pathway to Independence Award (K99/R00) program. The extension is limited to individuals whose eligibility period under the Parent K99/R00 would have ended between October 2024 – January 2026. LEARN MORE: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-25-121.html
- [11th IAS Conference on HIV Science, 18-21 July 2021](https://acsr1.com/11th-ias-conference-on-hiv-science-18-21-july-2021/) - Registration for the 11th International AIDS Society Conference on HIV Science, July 18-21, 2021, is OPEN! Standard registration for this virtual event closes on May 31st. For more information: https://www.ias2021.org/ Late-breaker abstract submission closes on May 10th, 2021. https://www.ias2021.org/abstracts/
- [FUNDING OPPORTUNITY ANNOUNCEMENT: Implementation Science for Cancer Control in People Living with HIV in Low and Middle Income Countries](https://acsr1.com/funding-opportunity-announcement-implementation-science-for-cancer-control-in-people-living-with-hiv-in-low-and-middle-income-countries/) - The purpose of this National Institutes of Health Funding Opportunity Announcement (FOA) is to support Implementation Science for Cancer Control in People Living with HIV (PLWH) in Low- and Middle-Income Countries (LMICs) to accelerate the integration of evidence-based cancer control interventions for PLWH by leveraging existing HIV treatment and prevention infrastructure. Specifically, this FOA
- [FUNDING OPPORTUNITY ANNOUNCEMENT: AIDS and Cancer Specimen Resource (ACSR) Young Investigator Pilot Award (YIPA) for FALL 2021](https://acsr1.com/funding-opportunity-announcement-aids-and-cancer-specimen-resource-acsr-young-investigator-pilot-award-yipa-for-fall-2021/) - The U.S. National Cancer Institute (NCI)-funded AIDS and Cancer Specimen Resource (ACSR) is pleased to announce the release of the Young Investigator Pilot Award (YIPA) for Fall 2021. We welcome applications for HIV-related research projects that will use specimens in the ACSR inventory, particularly for HIV malignancies, from early stage investigators who are within 8
- [Samantha Kendrick, 2015 ACSR YIPA awardee, in Lymphoma Research Foundation Pulse Magazine](https://acsr1.com/samantha-kendrick-pulse-magazine/) - The ACSR celebrates Samantha Kendrick, PhD, who is featured on pages 24-25 the winter issue of the Lymphoma Research Foundation Pulse magazine for a discussion of her research on diffuse large B-cell lymphoma. Dr. Kendrick was 1 of 4 inagural ACSR Young Investigator Pilot Award (YIPA) recipients (2015). Cheers to you, Dr. Kendrick. The ACSR
- [Office of HIV and AIDS Malignancy (NCI) KSHV Vaccine Workshop: October 13, 2021, 10:00 AM-5:30 PM EST](https://acsr1.com/oham-kshv-vaccine-workshop-oct13/) - It is our pleasure to share the following invitation from Drs. Geraldina Dominguez and Robert Yarchoan Office of HIV and AIDS Malignancy Dear Colleague: The Office of HIV and AIDS Malignancy (OHAM) in the National Cancer Institute is hosting a virtual workshop on Wednesday, October 13, 2021 from 10 AM-5:30 PM EST to discuss the need, potential,
- [NCI Webinar: "Creating biobanking infrastructures that enable return of results"- March 29](https://acsr1.com/nci-webinar-creating-biobanking-infrastructures-that-enable-return-of-results/) - The seminar series is brought to you by NCI’s Biorepositories and Biospecimen Research Branch (BBRB) and addresses current topics in biobanking science, policy and operations. In the era of precision medicine, high quality biospecimens are central to understanding complex diseases, biomarker discovery and unraveling the mechanisms of resistance to therapies. This seminar series is intended
- [AIDS Malignancy Consortium (AMC) Domestic Scholar Award - Applications due July 16, 2021](https://acsr1.com/aids-malignancy-consortium-amc-domestic-scholar-award-2021/)
- [UCSF News Center](https://acsr1.com/ucsf-news-center/) - ACSR featured on UCSF News Center AIDS and cancer specimen bank at UCSF renamed and funded for five more years... (Click to read more from the UCSF Archives)
- [New:  "Advancing HIV and Cancer Research: Implementing an AIDS and Cancer Specimen Resource in Latin America"](https://acsr1.com/new-advancing-hiv-and-cancer-research-implementing-an-aids-and-cancer-specimen-resource-in-latin-america/) - The latest from the ACSR, published in Biopreservation and Biobanking! Access the entire manuscript here: https://www.liebertpub.com/doi/epdf/10.1177/19475535251363861
- [NCI BBRB Webinar: Biobanking for Precision Medicine Series](https://acsr1.com/nci-bbrb-webinar-feb-16-biobanking-for-precision-medicine-series/) - Next Generation Biobanking: Operational and Regulatory Requirements for Reporting Results Clinically Biobanking for Precision Medicine Series Presented by the NCI Biorepositories and Biospecimen Research Branch Date: Wednesday, February 16, 2022, 1:00 - 2:30 p.m.Location: VirtualWebEx RegistrationOpen to the public. Registration using the WebEx link prior to the meeting is required to join this event. The seminar series
- [RFI on Research Opportunities & Operational Activities Related to the NIH Strategic Plan To Advance Research on the Health and Well-Being of Sexual & Gender Minorities](https://acsr1.com/rfi-on-research-opportunities-health-and-well-being-sgms/) - The Sexual & Gender Minority Research Office (SGMRO) is pleased to announce the publication of a Request for Information (RFI) on Research Opportunities and Operational Activities Related to the NIH Strategic Plan To Advance Research on the Health and Well-Being of Sexual & Gender Minorities (SGMs) Fiscal Years 2021-2025. The goal of this RFI is to provide
- [NCI Seeking Input from Cohort and Biorepository Researchers on Liquid Biopsy Studies for Early Cancer Detection](https://acsr1.com/nci-seeking-input-on-liquid-biopsy-studies-for-early-cancer-detection/) - National Cancer Institute RFI NOT-CA-22-010 solicits input on the availability of pre-diagnostic biospecimen collections which may be used for liquidbiopsy studies of early cancer detection and assess interest in participating in a collaborative workshop on evaluation of cancer early detection biomarkers. The NIH seeks comments on any or all of these topics listed below. If
- [A Plan for Emergency Shutdown and Reopening for a Consortium of Biobanks](https://acsr1.com/a-plan-for-emergency-shutdown-and-reopening-for-biobanks/) - The early months of the SARS-CoV-2 pandemic forced many laboratories and biobanks, including the ACSR, to develop contingency plans for biobank operations. Fear of the unknown, uncertainty and unpredictability, and the fluid nature of SARS-CoV-2 as a global threat, led to challenges in the continuity of supply chain operations, access to buildings and resources, and
- [17th International Conference on Malignancies in HIV/AIDS](https://acsr1.com/17th-international-conference-on-malignancies-in-hivaids/) - 17th ICMH Conference This meeting is presented by the Office of HIV and AIDS Malignancy, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services will take place October 21-22, 2019, at the Lister Hill Center Auditorium on the campus of the National Institutes of Health in Bethesda, Maryland. (READ MORE)
- [National HIV Testing Day June 27](https://acsr1.com/national-hiv-testing-day-june-27/) - June 27 is National HIV Testing Day (NHTD). On this day, the ACSR stands by partners, clinicians, researchers, organizations across the health care spectrum to raise awareness about the importance of HIV testing & early diagnosis of HIV. Help raise awareness about HIV testing. Let's stop HIV together.
- [New Cohort! NCI's Early Investigator Advancement Program (EIAP)](https://acsr1.com/nci-early-investigator-advancement-program/) - With the support of the Equity Council, NCI launched EIAP in late 2021 to facilitate the advancement of scientists from diverse backgrounds to become independent investigators. The cancer research enterprise needs a continuous flow of talent through the research career pipeline to thrive. One critical juncture is the transition from junior investigator to independent investigator.
- [NIH World AIDS Day Virtual Event, Wednesday, December 1, 2021](https://acsr1.com/nih-world-aids-day-virtual-event-2021/) - Join the Office of AIDS Research (OAR) for the NIH World AIDS Day Observance Wednesday, December 1, 2021, from 11:00 a.m. to 12:30 p.m. EST. Go to National Institute of Health World AIDS Day 2021 on the day of the event to watch the live videocast. This virtual event is open to the public. Entitled
- [Biden Awards $5.4 Million Inaugural Cohort of Cancer Moonshot Scholars](https://acsr1.com/biden-awards-5-4-million-inaugural-cohort-of-cancer-moonshot-scholars/) - The Biden-Harris Administration, through NCI, is committing $5.4 million in the first year of these multi-year awards to support the inaugural cohort of 11 Cancer Moonshot Scholars. The inaugural cohort of Cancer Moonshot Scholars is a program launched by President Biden last year to support early-career researchers and help build a cancer research workforce that
- [It's National Black HIV/AIDS Awareness Day](https://acsr1.com/national-black-hiv-aids-awareness-day/) - Today, February 7, National Black HIV/AIDS Awareness Day, join the ACSR as we acknowledge progress in HIV prevention and care among Black/African American people, while recognizing the work still needed. Let's work to stop HIV together by addressing HIV stigma & barriers.
- [February is National Cancer Prevention Month](https://acsr1.com/february-national-cancer-prevention-month/) - February is National Cancer Prevention Month and World Cancer Day is on February 4th. The ACSR is committed to advancing the science of cancer prevention. Screening, vaccines and making healthy lifestyle choices are all ways to lower your risk of getting cancer. The ACSR also stands by the the Union for International Cancer Control (UICC),
- [NEW Funding Opportunity: Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities](https://acsr1.com/new-funding-opportunity-impact-of-structural-racism-discrimination-on-minority-health-health-disparities/) - This initiative will support intervention research that addresses structural racism and discrimination (SRD) in order to improve minority health or reduce health disparities. Earliest submission date: February 24, 2023 Letter of intent due 30 days prior to submission. From FOA PAR-23-112 There is increasing recognition that racism and discrimination contribute to poorer health outcomes for
- [NCI Partnership: Self-Collection HPV Testing to Prevent Cervical Cancer](https://acsr1.com/nci-launches-self-collection-hpv-testing-to-prevent-cervical-cancer/) - It's National Cancer Prevention and Early Detection Month! Human papillomavirus (HPV) is the most the common sexually transmitted infection (STI) in the United States (per CDC's STD Facts on HPV), and is highly preventable by HPV vaccination, screening and treatment of cervical precancerous changes. The NCI Cervical Cancer ‘Last Mile’ Initiative, through a network of various partners,
- [Celebrating 20 Years of PEPFAR](https://acsr1.com/celebrating-20-years-of-pepfar/) - On Jan. 28, 2003, President George W. Bush announced the establishment of The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) during the State of the Union Address, leveraging years of HIV/AIDS research, coordinated humanitarian effort, bipartisan support from Congress, and engagement from community and faith-based organizations, and the private sector to create an unprecedented
- [World AIDS Day@35: "Let us finish the fight"](https://acsr1.com/world-aids-day35-let-us-finish-the-fight/) - The ACSR shares the same goal as millions around the world—to end the HIV epidemic. It will take a global effort, and we remain committed to supporting HIV/AIDS malignancy research to get it done. This World AIDS Day, take a moment to read the National HIV/AIDS Strategy (NHAS) and Federal Implementation Plan for information on how we
- [NEW from NCI Minute: ComboMatch](https://acsr1.com/new-from-nci-minute-combomatch/) - Learn more about ComboMATCH: the new clinical trial initiative to evaluate combinations of treatments that block both the drivers of tumor growth and the mechanisms of resistance. The primary goal for ComboMATCH is to see whether the use of drug combinations can overcome the resistance to treatment that can arise with the use of a single drug
- [Apply now! NCI Center for Global Health Fellowships](https://acsr1.com/apply-now-nci-center-for-global-health-fellowships/) - Are you interested in biomedical science or cancer research and control in low- and middle-income countries or global health communications? NCI’s Center for Global Health is now offering full-time, one-year fellowships based in Rockville, The positions provide opportunities for training and professional development. Fellows work with NCI staff to develop and implement projects that aim
- [Seventh person in the world effectively cured of HIV](https://acsr1.com/seventh-person-in-the-world-to-be-effectively-cured-of-hiv/) - A German man has become the seventh person in the world to be effectively cured of HIV after receiving a stem cell transplant to treat blood cancer. What makes this case especially noteworthy is that, unlike most previous cures, the transplant came from donor cells without the rare HIV-resistant gene mutation scientists once thought was
- [Register Now! NIH Workshop: Sept 26, 2025-Early Career Investigators in HIV](https://acsr1.com/nih-workshop-for-early-career-investigators-in-hiv/) - The National Institutes of Health (NIH) Office of AIDS Research (OAR) and partners across NIH invite you to attend the fourth annual Virtual Zoom Workshop for Early Career Investigators in HIV: Friday, September 26, 202511 a.m.-3 p.m. ET Early stage investigators, early career investigators and undergraduate and graduate students will have opportunities to: Learn about
- [ZERO HIV STIGMA DAY 2025- HIV stigma is a choice.](https://acsr1.com/zero-hiv-stigma-day-2025/) - July 21st is Zero HIV Stigma Day—a global movement that brings together individuals, communities, organizations, and nations to raise awareness and take action against HIV-related stigma. This stigma not only fuels the HIV epidemic but also deepens existing inequalities. While days like World AIDS Day focus on general awareness of HIV, Zero HIV Stigma Day
- [May is National Cancer Research Month](https://acsr1.com/may-is-national-cancer-research-month/) - May is National Cancer Research Month! The ACSR is proud to join the many organizations and cancer centers, institutions, researchers, physicians, patients, survivors, and advocates to bring awareness and highlight the importance and impact of cancer research. Learn more about the resources that bind us as partners in cancer research. AMERICAN CANCER SOCIETY (ACS): https://www.cancer.org/
- [“United by Unique": The NEW World Cancer Day campaign 2025-27](https://acsr1.com/united-by-unique-the-new-world-cancer-day-campaign-2025-27/) - February 4th is World Cancer Day. Cancer touches millions of lives in countless ways but it doesn't define who we are. We are more than a disease, more than a statistic. The new World Cancer Day campaign 2025-27 “United by Unique” places people at the center of care and will explore new ways of making a
- [SPORE program: a fitting mechanism for the study of HIV/AIDS-related malignancies](https://acsr1.com/spore-program-a-fitting-mechanism-for-the-study-of-hiv-aids-related-malignancies/) - On behalf of Toby T. Hecht, Ph.D. Associate Director, Translational Research Program, DCTD, NCI and Robert Yarchoan, M.D., Director, Office of HIV and AIDS Malignancy, NCI To the HIV Malignancy Community: During a panel discussion at the International Conference on Malignancies in HIV/AIDS (ICMH) this October, it was noted that a barrier to research in
- [Protocol for the simultaneous isolation of DNA, RNA, and miRNA from a single archived Kaposi sarcoma biopsy](https://acsr1.com/protocol-for-the-simultaneous-isolation-of-dna-rna-and-mirna-from-a-single-archived-kaposi-sarcoma-biopsy/) - HOT OFF THE PRESS! The ACSR is pleased to present its newest manuscript published in STAR Protocols, Protocol for the simultaneous isolation of DNA, RNA, and miRNA from a single archived Kaposi sarcoma biopsy. First author, Larissa Scholte summarizes: "In this study, we developed an innovative approach to process recalcitrant samples, not only to enhance
- [NEW! Lenacapavir injection advances HIV prevention in women](https://acsr1.com/lenacapavir-injection-advances-hiv-prevention-in-women/) - Favorable research results from the PURPOSE 1 trial (South Africa and Uganda) have been published in the New England Journal of Medicine and presented at IAS 2024 in Munich, use of the twice-yearly injectable lenacapavir (Gilead) has demonstrated 100% efficacy for HIV prevention in women. Results from PURPOSE 2, which is assessing efficacy of lenacapavir
- [Revisions to the NIH Fellowship Application and Review Process](https://acsr1.com/revisions-to-nih-fellowship-application-review-process/) - Have you heard? The National Institutes of Health (NIH) is revising the application and review criteria for fellowship applications, beginning with those submitted January 25, 2025 forward. Fellowship training awards are a critical part of the development of the research ecosystem. These revisions aim to broaden the pool of talented, emerging researchers. Below are resources
- [Be heard! NIH Strategic Plan for HIV and HIV-Related Research](https://acsr1.com/be-heard-nih-strategic-plan-for-hiv-and-hiv-related-research/) - The NIH Office of AIDS Research (OAR) has issued a Request for Information (RFI) to inform development of the FY 2026‒2030 NIH Strategic Plan for HIV and HIV-Related Research. Feedback from all interested parties—including researchers, health care professionals, advocates and health advocacy organizations, scientific or professional organizations, public health officials, government agencies, and community members—is
- [Congratulations, Dr. Kim Rathmell, NCI Director](https://acsr1.com/congratulations-dr-kim-rathmell-nci-director/) - The ACSR extends a warm welcome to Dr. Kim Rathmell, NCI Director. Dr. W. Kimryn Rathmell began her work as 17th director of the National Cancer Institute on December 18th when she was selected by President Biden to succeed Monica M. Bertagnolli, M.D., who left NCI to become the NIH director on November 9, 2023.
- [ACSR and Proscia Concentriq on the Web](https://acsr1.com/acsr-and-proscia-concentriq-press-release/) - We are thrilled to announce ACSR's highly valued relationship with Proscia®. Read the full release below for more on how enterprise digital pathology thru Proscia Concentriq is helping the ACSR to support and advance scientific exploration in cancer in people living with HIV.
- [NIH Request for Information (RFI) on Research Opportunities Related to HIV and Women’s Health](https://acsr1.com/nih-rfi-on-research-opportunities-related-to-hiv-and-womens-health/) - From https://grants.nih.gov/grants/guide/notice-files/NOT-OD-24-011.html The National Institutes of Health (NIH) Office of AIDS Research (OAR) and Office of Research on Women's Health (ORWH) launched a joint HIV and Women Signature Program in 2023 to advance the NIH vision for women's health – a world in which every woman, including cisgender, transgender, and gender-diverse women, receives evidence-based care, prevention, and treatment tailored
- [Notice to Announce NIH Updated Policy Guidance for Subaward/Consortium](https://acsr1.com/notice-to-announce-nih-updated-policy-guidance-for-subaward-consortium/) - BE HEARD! NIH is seeking public comment on updates to the NIH Grants Policy Statement (NIHGPS), Section 15.2, which outlines the requirements for consortium/subaward agreements on NIH-funded grants, including new reporting requirements for non-US subrecipients. Comments are due by 6/26/2023! For more information and to submit your comments visit: https://rfi.grants.nih.gov/?s=646e6654a8ba09024f09e852
- [NEW: KSHV Vaccine Notice of Intent to Publish Funding Opportunity](https://acsr1.com/new-kshv-vaccine-notice-of-intent-to-publish/) - The National Cancer Institute (NCI) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to solicit applications to expand the research scope and leverage the gains made through the “Investigation of the Transmission of KSHV” initiatives (RFA-CA-18-013 and RFA-CA-20-046) to support basic and translational research that will guide the development
- [NEW funding opportunities in HPV-OPC research](https://acsr1.com/new-funding-hpv-opc-research/) - Two new research opportunities from NIH/NCI! The purpose of these Notice of Funding Opportunity (NOFO) is to solicit developmental/exploratory research to better understand the mechanisms of persistent oral human papillomavirus (HPV) and human immunodeficiency virus (HIV) co-infection as well as its role in the induction and pathogenesis of HPV-associated oropharyngeal cancers (HPV-OPC). For more information,
- [Introducing the National Cancer Plan](https://acsr1.com/the-national-cancer-plan/) - We all know someone who has been affected by cancer. With the progress made in research, technology, medicine, science, healthcare and legislature since the National Cancer Act was signed into law in 1971, it is no longer unthinkable to end cancer altogether. The National Cancer Institute's National Cancer Plan will align broad societal engagement and
- [ASCO2023 Early Registration is Open](https://acsr1.com/asco2023-annual-meeting/) - Calling all oncology professionals! The ASCO 2023 Virtual and In-Person Annual Meeting will be held on June 2-6, McCormick Place, Chicago, IL. Secure the best rates by registering before April 26. Don't miss out on the annual opportunity to connect with one of the largest, most diverse audiences in global cancer care. Discover the latest
- [Apply now! NCI Center for Global Health Fellowships](https://acsr1.com/nci-center-for-global-health-fellowships/) - Are you interested in biomedical science or cancer research and control in low- and middle-income countries or global health communications? NCI's Center for Global Health is now offering full-time, one-year fellowships based in Rockville, MD. The positions provide opportunities for training and professional development. Fellows work with NCI staff to develop and implement projects that
- [Happy New Year from the ACSR](https://acsr1.com/happy-new-year-from-the-acsr/) - As we begin the new year, we take this time to celebrate the National Institutes of Health (NIH)-supported promising medical findings in 2022, including progress toward an HIV vaccine. https://www.nih.gov/news-events/nih-research-matters/2022-research-highlights-promising-medical-findings May peace, joy, hope and good health be ours in the year ahead!
- [World AIDS Day, December 1, 2022  #EQUALIZE](https://acsr1.com/world-aids-day-december-1-2022/) - Today, World Aids Day, we wear our virtual red ribbon, the universal symbol of support of people living with HIV/AIDS, families, caregivers, clinicians, researchers, organizations across the health care spectrum who are committed to ending the HIV epidemic. Let's unite to end the inequalities holding back the end of the AIDS pandemic. This World AIDS
- [World AIDS Day, December 1, 2021](https://acsr1.com/world-aids-day-december-1-2021/) - End inequalities. End AIDS. End pandemics. Today, World Aids Day, we wear our virtual red ribbon, the universal symbol of support of people living with HIV/AIDS, families, caregivers, clinicians, researchers, organizations across the health care spectrum who are committed to ending the HIV epidemic. Visit the resources below to learn more for yourself, a friend,
- [September 24 is World Cancer Research Day](https://acsr1.com/september-24-is-world-cancer-research-day/) - September 24th is WORLD CANCER RESEARCH DAY. ACSR is committed to supporting innovative research to improve the delivery of equitable cancer care. We celebrate our colleagues who are committed to ending cancer as we know it. To learn more about World Cancer Research Day https://www.worldcancerresearchday.com/
- [Now Availaible! 2022 AACR Cancer Disparities Progress Report](https://acsr1.com/now-availaible-2022-aacr-cancer-disparities-progress-report/) - The AACR Cancer Disparities Progress Report 2022 is now available. The report highlights the progress being made toward cancer health equity and issues a call to action to eliminate cancer disparities. To download the report click here: https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2022/06/AACR_CDPR_2022.pdf For more information about how the AACR is working to achieve health equity for racial and ethnic
- [Notice of Administrative Supplements for NCI Global Oncology Mentored Research](https://acsr1.com/administrative-supplements-for-nci-global-oncology-mentored-research/) - The purpose of this Notice is to encourage current funded NCI extramural investigators to apply for administrative supplements to support mentored cancer research career development of early-stage low- and middle-income country (LMIC) investigators (ESLIs). The overarching goal of this supplement opportunity is to strengthen the capacity of LMIC investigators to conduct high-quality research in their
- [Apply Now! AACR-Genmab Non-Hodgkin B-cell Lymphoma Research Fellowship](https://acsr1.com/apply-now-aacr-genmab-non-hodgkin-b-cell-lymphoma-research-fellowship/) - The American Association for Cancer Research (AACR)-Genmab Non-Hodgkin B-cell Lymphoma Research Fellowship provides a two-year grant of $120,000 to support the salary and benefits of a postdoctoral or clinical research fellow to encourage and support the establishment of a successful career path in non-Hodgkin B-cell lymphoma. Application deadline is May 19, 2022. https://www.aacr.org/grants/aacr-genmab-non-hodgkin-b-cell-lymphoma-research-fellowship/
- [Today is World Health Day!](https://acsr1.com/today-is-world-health-day/) - Our Planet, Our Health Today, on World Health Day 2022, the ACSR joins the World Health Organization and other global health organizations in recognizing the importance of science, technology, innovation, and stewardship in creating a healthier tomorrow. Looking for ways to do your part? Visit the website to learn more about this year's theme, "Our
- [NEW NCI P30s Administrative Supplement Opportunities for AIDS-Related Malignancies](https://acsr1.com/new-nci-p30s-administrative-supplement-opportunities-for-aids-related-malignancies/) - The ACSR is pleased to share the following NIH/NCI funding opportunities. 1. Administrative Supplements for P30 Cancer Centers Support Grants (CCSG) to Stimulate Research in HIV/AIDS Cancer Research Projects at NCI-designated Cancer Centers (Biospecimens/Biocohort) Read the full RFA here. Applications are due 5/9/22 Leadership of projects by junior or mid-level investigators is encouraged. Two years
- [ACSR Invites You To Break The Bias- International Women's Day, March 8](https://acsr1.com/acsr-invites-you-to-break-the-bias-international-womens-day-march-8/) - This week, the ACSR invites you to celebrate the achievements of all women – past and present – reflecting on both how far we have come and where we still need to grow. Together we can forge women's equality. Collectively we can all work towards the 2022 International Women's Day theme of "Breaking the Bias".
- [New Research: Stem Cell Transplant Cures Woman Living With HIV](https://acsr1.com/new-research-stem-cell-transplant-cures-woman-living-with-hiv/) - Use of stem cells for research has not be conducted without its share of controversy. New research using a new transplant method involving umbilical cord blood, presented at this year's virtual Conference on Retroviruses and Opportunistic Infections (February 12-16), provides hope for placing more people living with HIV in remission. More notably, this research has
- [New NCI FOA supports the development of cancer-relevant technologies for use in LMICs](https://acsr1.com/new-nci-foa-supports-the-development-of-cancer-relevant-technologies-for-use-in-lmics/) - NOT-CA-22-031 Notice of Intent to Publish a Funding Opportunity Announcement for Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) The purpose of this announcement is to alert the community that the National Cancer Institute (NCI) plans to publish a Funding Opportunity Announcement (FOA) to invite applications for Cancer Prevention,
- [A highly virulent variant of HIV-1 circulating in the Netherlands](https://acsr1.com/hiv-variant-circulating-in-the-netherlands/) - Our recent experiences with the coronavirus pandemic have demonstrated that new mutations in viral genetic sequences can have significant impacts on the virus's transmissibility and the degrees of illness it causes. Recently, the same has been demonstrated with the HIV virus, which has caused 36.3 million deaths to date, per the World Health Organization. Researchers
- [World Cancer Day is on February 4. The time to act is now.](https://acsr1.com/world-cancer-day-february-4/) - World Cancer Day, observed on February 4th, annually, is the global uniting initiative led by the Union for International Cancer Control (UICC). By raising worldwide awareness, improving education, advocatitng for research and catalysing personal, collective and government action, we all work together to reimagine a world where millions of preventable cancer deaths are saved and
- [New research suggests Pembrolizumab could help flush HIV from its hiding spots](https://acsr1.com/research-suggests-pembro-could-help-flush-hiv-from-hiding/) - How do HIV/AIDS & cancer research continue to converge? Read more about the early results from a novel study which shows that pembrolizumab, a cancer drug, can flush HIV from hiding spots in immune cells. Yet another important step toward curing HIV and ending the HIV epidemic. Via Stat News: https://www.statnews.com/2022/01/26/latent-hiv-pembrolizumab-keytruda/ From Science Translational Medicine:
- [Symposium: Maximizing the Research Use of Small Biopsy Tissue](https://acsr1.com/symposium-maximizing-the-research-use-of-small-biopsy-tissue/) - The National Cancer Institute’s Cancer Moonshot(SM) Biobank will be hosting a mini-symposium on “Maximizing the Research Use of Small Biopsy Tissue” on Wednesday, February 9th from 9AM-12 PM EST. This mini symposium will highlight and address challenges and successful approaches for obtaining biopsies, appropriate tissue handling, and subsequent analysis that results in sufficient quality and
- [50th Anniversary of the National Cancer Act](https://acsr1.com/50th-anniversary-of-the-national-cancer-act/) - Yesterday, the White House issued a proclamation to recognize today's 50th anniversary of President Nixon's signing of the National Cancer Act, recommitting to the investment in people and science to end cancer as we know it. The ACSR stands with Pres. Biden, the First Lady, patients, families, healthcare providers, researchers, and catalysts for change and
- [New NCI FOA for Biospecimen Science Programs and Biorepositories PAR-22-049](https://acsr1.com/nci-foa-for-biospecimen-science-programs-par-22-049/) - Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trials Not Allowed) Attention Biorepositories and Biospecimen Science Programs! The earliest submission date for this National Cancer Institute Funding Opportunity Announcement (FOA) is December 11, 2021. This NCI FOA will support extramural research to investigate and mitigate challenges facing clinical assay development and subsequent analytical
- [Registration for ASCO June 3-7, 2022 is now open!](https://acsr1.com/registration-for-asco-june-3-7-2022-is-now-open/) - Member-only registration is open for the hybrid ASCO Annual Meeting, June 3-7, 2022 at McCormick Place, Chicago, IL and online! General registration opens in mid-December. https://conferences.asco.org/am/attend Join more than 40,000 oncology professionals from around the world at the 2022 ASCO Annual Meeting- a unique and unparalleled opportunity to connect with one of the largest,
- [24th International AIDS Conference: 29 July – 2 August 2022 Montreal, Canada & virtually](https://acsr1.com/the-24th-ias-conference-2022/) - Registration and abstract submission to 24th International AIDS Conference opens on November 16th! #IAS2022 is scheduled to take place from 29 July – 2 August 2022: Montreal, Canada, and virtually. For more information visit the conference website: https://aids2022.org/ The International AIDS Conference is the largest gathering on HIV and AIDS in the world. First convened
- [63rd ASH Annual Meeting & Exposition, Georgia World Congress Center in Atlanta, Georgia,December 11-14, 2021](https://acsr1.com/63rd-ash-annual-meeting-exposition-2021/) - In-person and virtual registration for the 63rd ASH Annual Meeting & Exposition, Georgia World Congress Center in Atlanta, Georgia – from December 11-14, 2021 is now open. Discover the newest advances in hematology. Register for #ASH21 today!
- [Call for Abstracts now open!  AACR Annual Meeting 2022 | April 8-13, 2022 | New Orleans](https://acsr1.com/call-for-abstracts-now-open-aacr-annual-meeting-2022-april-8-13-2022-new-orleans/) - #AACR22 Abstract Submission is open!! Submission Deadline is November 18. 2021 Housing: Open September 21; Reservation Deadline February 25, 2022 Registration: Opens mid-Oct; Advance Registration Deadline February 18, 2022 >AACR Annual Meeting 2022 | April 8-13, 2022 | New Orleans Decoding Cancer Complexity | Integrating Science | Transforming Patient Outcomes
- [ACSR's NCI Partner, Dr. Rebecca Liddell Huppi quoted on NCI Global Health Twitter](https://acsr1.com/acsrs-nci-partner-dr-rebecca-liddell-huppi-global-health-twitter/) - Kudos to Dr. Rebecca Liddell Huppi, the ACSR's NCI Partner, on the NCI Global Health tweet which featured her quote about the significance of global health. To learn more about the NCI's Office of HIV and AIDS Malignancy, visit their website. https://www.cancer.gov/about-nci/organization/oham
- [ACSR's Patricia Castro, PhD at ISBER 2021 Annual Meeting, May 13, 2021](https://acsr1.com/acsrs-patricia-castro-phd-at-isber-2021-annual-meeting-may-13-2021/) - Congratulations! to our very own Patricia Castro, PhD, who will deliver her abstract entitled Application of Natural Language Processing for Biorepositories at the upcoming International Society for Biological and Environmental Repositories (ISBER) 2021 Annual Meeting & Exhibits. The full virtual meeting is scheduled to take place May 10-14. Tune in on Thursday 5/13 to catch
- [World Health Day, April 7, 2021](https://acsr1.com/world-health-day-april-7-2021/) - In honor of World Health Day 2021, the ACSR acknowledges the professionals across the healthcare continuum for their extraordinary efforts to build a fairer, healthier world, especially during these unprecedented times. For more information about how you can build a fairer, healthier world, visit the World Health Organization's World Health Day page.
- [EBV-tissue positive primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity](https://acsr1.com/ebv-tissue-positive-primary-cns-lymphoma-occurring-after-immunosuppression-is-a-distinct-immunobiological-entity/) - Using ACSR Specimens, Colm Keane et al. give us the largest in-depth description of the biology of Primary Central Nervous Lymphoma occurring in patients with AIDS. This disease demonstrates a unique genetic and immunological biology that differs markedly from the same disease in immunocompetent patients. These findings are a first step to help define better
- [Conference on Retroviruses and Opportunistic Infections (CROI) 2019](https://acsr1.com/conference-on-retroviruses-and-opportunistic-infections-croi-2019/) - CROI 2019 The annual Conference on Retroviruses and Opportunistic Infections (CROI) will be held from March 4 to March 7, 2019, at the Washington State Convention Center in Seattle, Washington. (READ MORE)
- [9th International AIDS Society Conference](https://acsr1.com/9th-ias-conference-on-hiv-science-ias-2017/) - 9th IAS Conference on HIV Science The Paris Statement: HIV Science Matters Ending the epidemic requires the continued contribution of and investment in science. (READ MORE)

## Pages

- [About Us](https://acsr1.com/) - AIDS and Cancer Specimen Resource (ACSR) is a biorepository for HIV human biospecimens for the scientific research community-at-large.
- [Tissue Microarrays](https://acsr1.com/tissue-microarrays/) - TMAs Tissue Microarrays (TMAs) Digital Library KS (HIV related) Lymphoma (HIV related) Lymphoma (HIV negative) Non-AIDS-defining Cancers (HIV related) Melanoma (HIV related) Multsite Autopsies (HIV related NHL) Multsite Autopsies (HIV related KS) Multisite Autopsies (HIV related Lung Cancer) Antiretrovirals in Kaposi Sarcoma (KS-ARKS) Investigators requesting access to view Tissue Microarray (TMA) images are required to
- [Links](https://acsr1.com/links/) - Links from AIDS and Cancer Specimen Resource
- [About Us](https://acsr1.com/about-us/) - The commitment of the ACSR is to encourage research in the field of HIV-associated malignancies, both AIDS defining and non-AIDS defining by studying biospecimens.
- [Request access to the Virtual Biorepository](https://acsr1.com/specimens/request-access-to-virtual-biorepository/) - A limited number of images are available for viewing in the ACSR Virtual Public Repository. Investigators requesting access to view Tissue Microarray (TMA) images for their research are required to complete the ACSR’s Image Access Agreement. By submitting this form, the investigator hereby agrees that the images provided by the NCI’s AIDS and Cancer Specimen Resource
- [Standard Operating Procedures](https://acsr1.com/sop/) - The ACSR sites work collaboratively to develop accepted Policies and Standard Operating Procedures. All file downloads are in PDF format. If you wish to modify these SOPs for local use, contact the ACSR (contact@acsr1.com) to request the MS Word documents. When adapting SOPs for local use please reference the original ACSR SOP(s) in your document
- [Biospecimens](https://acsr1.com/biospecimens-2/) - The AIDS and Cancer Specimen Resource develops special sets of specimens involved in clinical trials, Internationally obtained specimens from all HIV/AIDS risk categories
- [Specimens](https://acsr1.com/specimens/) - Aids and Cancer Specimen Resource maintains databank of prognostic, staging, outcome and treatment data on HIV/AIDS patients from whom tissues were obtained.
- [Resources](https://acsr1.com/resources-2/)
- [Manuscripts](https://acsr1.com/manuscripts/) - Listing of manuscripts and abstracts utilizing ACSR specimens provided by AIDS and Cancer Specimen Resource, funded by the National Cancer Institute is found here.
- [Request Specimens](https://acsr1.com/request-specimens/) - Request HIV/AIDS specimens from the Aids and Cancer Specimen Resource.
- [Inventory Explorer](https://acsr1.com/inventory-explorer/) - Welcome to the new BETA VERSION of the ACSR Inventory Explorer! Please be patient with us as we continue to develop this tool. We welcome your feedback! The ACSR Inventory Explorer is a de-identified visualization of the ACSR specimen databases. Because the data contains no PHI, it is not subject to HIPAA restrictions on research
- [More From the Web](https://acsr1.com/fromthe-web/) - ACSR Videos on Jove
- [ACSR Funding Opportunities](https://acsr1.com/resources/acsr-funding-opportunities/) - MEET OUR YOUNG INVESTIGATOR PILOT AWARD RECIPIENTS! The ACSR is committed to supporting the next generation of HIV researchers by offering a grant award program for early-stage investigators interested in conducting HIV-related research, especially for malignancies. The goal is to encourage novel and rigorous scientific research projects that utilize biospecimens and data in the ACSR
- [FAQS](https://acsr1.com/faqs/) - The AIDS and Cancer Specimen Resource is a biorepository that provides biospecimens to independently funded, IRB approved researchers in the area of HIV/AIDS investigations
- [Our Specimens](https://acsr1.com/our-specimens/) - Explore Our Inventory The ACSR is happy to assist researchers in determining the availability of samples required for their research. Exact numbers of specimens available, particularly for rare sample types/diagnoses, cannot be guaranteed as our inventory is dynamic. To learn more about the availability of samples required for your research, contact us! Tissue Microarrays (TMAs) in
- [Contact Us](https://acsr1.com/contact/) - Contact The AIDS and Cancer Specimen Resource | The biorepository for biospecimens with HIV/AIDS.
- [ACSR Young Investigator Pilot Award](https://acsr1.com/pilot/) - The ACSR Young Investigator Pilot Award (YIPA) is targeted toward junior investigators and faculty with innovative ideas for translational, clinical and/or behavioral-epidemiological HIV-related research that utilizes ACSR’s annotated biospecimens collected from people living with HIV/AIDS and controls from both pre and post-HAART periods. Awards are intended for pilot studies to show feasibility and/or to generate
- [Inventory Explorer](https://acsr1.com/inventory-explorer-2/) - The Inventory Explorer is down for maintenance today! Check back soon!
- [Funding Opportunities](https://acsr1.com/funding-opportunity/) - ACSR Funding Opportunities MEET OUR YOUNG INVESTIGATOR PILOT AWARD AWARDEES! The ACSR is committed to supporting the next generation of HIV researchers by offering a grant award program for early-stage investigators interested in conducting HIV-related research, especially for malignancies. The goal is to encourage novel and rigorous scientific research projects that utilize biospecimens and
- [Biospecimens](https://acsr1.com/biospecimens/)
- [Our Specimens](https://acsr1.com/our-specimens-2/)
- [News & Events](https://acsr1.com/news-and-events/) - Seventh person in the world effectively cured of HIV Register Now! NIH Workshop: Sept 26, 2025-Early Career Investigators in HIV New: “Advancing HIV and Cancer Research: Implementing an AIDS and Cancer Specimen Resource in Latin America” Posts Navigation
- [Image Access Form](https://acsr1.com/contact/image-access-form/) - Request access to Digital Biospecimen Repository
- [Leadership Profiles](https://acsr1.com/leadership-profile/) - The management profiles of Aids and Cancer Specimen Resource provide valuable insight into cancer epidemiology, AIDS malignancies and HIV infected macrophages.
- [Resources](https://acsr1.com/resources/)
- [Data Explorer](https://acsr1.com/data-explorer/) - PLEASE USE THE DATA DIMENSION FILTER ON THE TOP LEFT AS WELL AS FILTERS ON THE RIGHT HAND SIDE THEN CLICK ON FULL SCREEN MODE AT THE BOTTOM OF THE EXPLORER FOR AN ENGAGING INTERACTIVE EXPERIENCE. Please choose the data dimension of interest from drop down menu then filter by selecting a data field or
- [Data Explorer Form](https://acsr1.com/biospecimens-2/data-explorer/) - Request for access to Data Explorer
- [Publication](https://acsr1.com/publication/) - Listing of manuscripts and abstracts utilizing ACSR specimens provided by AIDS and Cancer Specimen Resource, funded by the National Cancer Institute is found here.
- [Your Profile](https://acsr1.com/your-profile/)
- [Contact Form](https://acsr1.com/contact/contact-form/) - Request for Information
- [Search](https://acsr1.com/search/)
- [Opportunities](https://acsr1.com/funding-opportunities/) - Research Opportunities for the AIDS and Cancer Specimen Resource
- [Aperio](https://acsr1.com/aperio/) - http://acsr.slidehosting.com You may access the site using these login credentials: username: ACSRslides password: n3wsite4TEST! After login, choose Courses to select your class, then select the appropriate Lesson
- [ACSR Pilot Award](https://acsr1.com/acsr-pilot-award/) - See more.....

## News

- [19th International Workshop on Kaposi's Sarcoma Associated Herpesvirus (KSHV) and Related Agents, Los Angeles, CA; July 19-22](https://acsr1.com/news_ticker/16th-intl-workshop-kshv-june-30-to-july-3-puerto-vallarta-mexico/)

## Categories

- [Uncategorized](https://acsr1.com/category/uncategorized/)
- [Conference](https://acsr1.com/category/conference/)
- [Funding Opportunity](https://acsr1.com/category/funding-opportunity/)
- [News](https://acsr1.com/category/news/)
- [ACSR](https://acsr1.com/category/acsr/) - Aids and Cancer Specimen Resource
- [Publication](https://acsr1.com/category/publication/)
- [Job Opportunity](https://acsr1.com/category/job-opportunity/)
- [Abstract](https://acsr1.com/category/abstract/)
- [Webinar](https://acsr1.com/category/webinar/)
- [Seminar](https://acsr1.com/category/seminar/)
- [Request For Information](https://acsr1.com/category/request-for-information/)
- [Virtual Event](https://acsr1.com/category/virtual-event/)
- [Video](https://acsr1.com/category/video/)
- [In Memoriam](https://acsr1.com/category/in-memoriam/)
- [Fellowship Opportunity](https://acsr1.com/category/fellowship-opportunity/)

## Tags

- [YIPA](https://acsr1.com/tag/yipa/)
- [Pilot Award](https://acsr1.com/tag/pilot-award/)
- [Young Investigator](https://acsr1.com/tag/young-investigator/)
- [AACR](https://acsr1.com/tag/aacr/)
- [IAS](https://acsr1.com/tag/ias/)
- [ISBER](https://acsr1.com/tag/isber/)
- [KSHV](https://acsr1.com/tag/kshv/)
- [NCI](https://acsr1.com/tag/nci/)
- [R01](https://acsr1.com/tag/r01/)
- [Conference](https://acsr1.com/tag/conference/)
- [HIV](https://acsr1.com/tag/hiv/)
- [Cancer](https://acsr1.com/tag/cancer/)
- [Research](https://acsr1.com/tag/research/)
- [Biorepository](https://acsr1.com/tag/biorepository/)
- [News](https://acsr1.com/tag/news/)
- [ACSR](https://acsr1.com/tag/acsr/)
- [AMC](https://acsr1.com/tag/amc/)
- [NIH](https://acsr1.com/tag/nih/)
- [PLOS ONE](https://acsr1.com/tag/plos-one/)
- [Publication](https://acsr1.com/tag/publication/)
- [JAMA](https://acsr1.com/tag/jama/)
- [Oncology](https://acsr1.com/tag/oncology/)
- [FFPE](https://acsr1.com/tag/ffpe/)
- [ASH](https://acsr1.com/tag/ash/)
- [TMA](https://acsr1.com/tag/tma/)
- [ICMH](https://acsr1.com/tag/icmh/)
- [ICMAOI](https://acsr1.com/tag/icmaoi/)
- [Fellowship](https://acsr1.com/tag/fellowship/)
- [HAMB](https://acsr1.com/tag/hamb/)
- [Tenure](https://acsr1.com/tag/tenure/)
- [Investigator](https://acsr1.com/tag/investigator/)
- [OHAM](https://acsr1.com/tag/oham/)
- [RFA](https://acsr1.com/tag/rfa/)
- [AIDS](https://acsr1.com/tag/aids/)
- [EBV](https://acsr1.com/tag/ebv/)
- [Infectious Diseases](https://acsr1.com/tag/infectious-diseases/)
- [CROI](https://acsr1.com/tag/croi/)
- [Funding opportunity](https://acsr1.com/tag/funding-opportunity/)
- [Covid-19](https://acsr1.com/tag/covid-19/)
- [Notice of special interest](https://acsr1.com/tag/notice-of-special-interest/)
- [SARS-CoV-2](https://acsr1.com/tag/sars-cov-2/)
- [Annual Meeting](https://acsr1.com/tag/annual-meeting/)
- [FOA](https://acsr1.com/tag/foa/)
- [AIDS Research](https://acsr1.com/tag/aids-research/)
- [CFAR](https://acsr1.com/tag/cfar/)
- [Using ACSR samples](https://acsr1.com/tag/using-acsr-samples/)
- [DNA repair](https://acsr1.com/tag/dna-repair/)
- [HIV related DLBCL](https://acsr1.com/tag/hiv-related-dlbcl/)
- [diffuse large B-cell lymphoma](https://acsr1.com/tag/diffuse-large-b-cell-lymphoma/)
- [#ASCO20](https://acsr1.com/tag/asco20/)
- [ASCO](https://acsr1.com/tag/asco/)
- [Virtual Conference](https://acsr1.com/tag/virtual-conference/)
- [DLBCL](https://acsr1.com/tag/dlbcl/)
- [ACSR Research](https://acsr1.com/tag/acsr-research/)
- [Alanna Maguire](https://acsr1.com/tag/alanna-maguire/)
- [ACSR website](https://acsr1.com/tag/acsr-website/)
- [ACSR email](https://acsr1.com/tag/acsr-email/)
- [contact ACSR](https://acsr1.com/tag/contact-acsr/)
- [ACSR Research Christine King](https://acsr1.com/tag/acsr-research-christine-king/)
- [Kaposi Sarcoma](https://acsr1.com/tag/kaposi-sarcoma/)
- [CRUK](https://acsr1.com/tag/cruk/)
- [Request for application](https://acsr1.com/tag/request-for-application/)
- [World AIDS Day](https://acsr1.com/tag/world-aids-day/)
- [Office of AIDS Research](https://acsr1.com/tag/office-of-aids-research/)
- [AACR21](https://acsr1.com/tag/aacr21/)
- [CNS Lymphoma](https://acsr1.com/tag/cns-lymphoma/)
- [Rosalind](https://acsr1.com/tag/rosalind/)
- [NanoString Technologies](https://acsr1.com/tag/nanostring-technologies/)
- [World Cancer Day](https://acsr1.com/tag/world-cancer-day/)
- [#iamandiwill](https://acsr1.com/tag/iamandiwill/)
- [LMIC](https://acsr1.com/tag/lmic/)
- [health equity](https://acsr1.com/tag/health-equity/)
- [world health day 2020](https://acsr1.com/tag/world-health-day-2020/)
- [WHO](https://acsr1.com/tag/who/)
- [AIDS Malignancy Consortium](https://acsr1.com/tag/aids-malignancy-consortium/)
- [#IAS2021](https://acsr1.com/tag/ias2021/)
- [Office of HIV and AIDS Malignancy](https://acsr1.com/tag/office-of-hiv-and-aids-malignancy/)
- [National HIV Testing Day](https://acsr1.com/tag/national-hiv-testing-day/)
- [HPV](https://acsr1.com/tag/hpv/)
- [oral human papillomavirus](https://acsr1.com/tag/oral-human-papillomavirus/)
- [Global Cancer Research](https://acsr1.com/tag/global-cancer-research/)
- [NCI Global Health](https://acsr1.com/tag/nci-global-health/)
- [Human Papillomavirus](https://acsr1.com/tag/human-papillomavirus/)
- [Vaccine](https://acsr1.com/tag/vaccine/)
- [Abstract](https://acsr1.com/tag/abstract/)
- [Request for information](https://acsr1.com/tag/request-for-information/)
- [SGMs](https://acsr1.com/tag/sgms/)
- [SGMRO](https://acsr1.com/tag/sgmro/)
- [SOP](https://acsr1.com/tag/sop/)
- [T-cell Lymphoma](https://acsr1.com/tag/t-cell-lymphoma/)
- [Lymphoma](https://acsr1.com/tag/lymphoma/)
- [IAS2020](https://acsr1.com/tag/ias2020-2/)
- [Abstract Submission](https://acsr1.com/tag/abstract-submission/)
- [Registration](https://acsr1.com/tag/registration/)
- [RFI](https://acsr1.com/tag/rfi/)
- [Biorepository research](https://acsr1.com/tag/biorepository-research/)
- [Liquid biopsy](https://acsr1.com/tag/liquid-biopsy/)
- [HIV research](https://acsr1.com/tag/hiv-research/)
- [Cancer research](https://acsr1.com/tag/cancer-research/)
- [National Cancer Act](https://acsr1.com/tag/national-cancer-act/)
- [#NothingWillStopUs](https://acsr1.com/tag/nothingwillstopus/)
- [Endemic Burkitt Lymphoma](https://acsr1.com/tag/endemic-burkitt-lymphoma/)
- [#EndCancerAsWeKnowIt](https://acsr1.com/tag/endcancerasweknowit/)
- [Plasma EBV DNA](https://acsr1.com/tag/plasma-ebv-dna/)
- [Diagnostic Markers](https://acsr1.com/tag/diagnostic-markers/)
- [HIV research centers](https://acsr1.com/tag/hiv-research-centers/)
- [Cancer Moonshot](https://acsr1.com/tag/cancer-moonshot/)
- [Conference Registration](https://acsr1.com/tag/conference-registration/)
- [Biobanking](https://acsr1.com/tag/biobanking/)
- [pembrolizumab](https://acsr1.com/tag/pembrolizumab/)
- [keytruda](https://acsr1.com/tag/keytruda/)
- [#CloseTheCareGap](https://acsr1.com/tag/closethecaregap/)
- [HIV Variant](https://acsr1.com/tag/hiv-variant/)
- [Variant](https://acsr1.com/tag/variant/)
- [STEM](https://acsr1.com/tag/stem/)
- [Women in Science](https://acsr1.com/tag/women-in-science/)
- [Equity](https://acsr1.com/tag/equity/)
- [Diversity](https://acsr1.com/tag/diversity/)
- [inclusion](https://acsr1.com/tag/inclusion/)
- [SDG 6](https://acsr1.com/tag/sdg-6/)
- [NCI BBRB](https://acsr1.com/tag/nci-bbrb/)
- [biospecimen banking](https://acsr1.com/tag/biospecimen-banking/)
- [next generation biobanking](https://acsr1.com/tag/next-generation-biobanking/)
- [webinar](https://acsr1.com/tag/webinar/)
- [precision medicine](https://acsr1.com/tag/precision-medicine/)
- [stem cells](https://acsr1.com/tag/stem-cells/)
- [hiv cure](https://acsr1.com/tag/hiv-cure/)
- [transplant](https://acsr1.com/tag/transplant/)
- [PLWH](https://acsr1.com/tag/plwh/)
- [HPV Vaccine](https://acsr1.com/tag/hpv-vaccine/)
- [HPV Awareness](https://acsr1.com/tag/hpv-awareness/)
- [#onelessworry](https://acsr1.com/tag/onelessworry/)
- [#askabouthpv](https://acsr1.com/tag/askabouthpv/)
- [#breakthebias](https://acsr1.com/tag/breakthebias/)
- [international women's day](https://acsr1.com/tag/international-womens-day/)
- [IWD2022](https://acsr1.com/tag/iwd2022/)
- [diversity equity inclusion](https://acsr1.com/tag/diversity-equity-inclusion/)
- [women in stem](https://acsr1.com/tag/women-in-stem/)
- [girls in stem](https://acsr1.com/tag/girls-in-stem/)
- [Global Health](https://acsr1.com/tag/global-health/)
- [PEPFAR](https://acsr1.com/tag/pepfar/)
- [GFATM](https://acsr1.com/tag/gfatm/)
- [BBRB webinar](https://acsr1.com/tag/bbrb-webinar/)
- [AIDS Malignancy](https://acsr1.com/tag/aids-malignancy/)
- [P30](https://acsr1.com/tag/p30/)
- [World Health Day 2022](https://acsr1.com/tag/world-health-day-2022/)
- [World Health Organization](https://acsr1.com/tag/world-health-organization/)
- [Genmab](https://acsr1.com/tag/genmab/)
- [NHBCL](https://acsr1.com/tag/nhbcl/)
- [Research Fellowship](https://acsr1.com/tag/research-fellowship/)
- [Lymphoma Research](https://acsr1.com/tag/lymphoma-research/)
- [Global Oncology](https://acsr1.com/tag/global-oncology/)
- [International Conference on Malignancies in HIV/AIDS](https://acsr1.com/tag/international-conference-on-malignancies-in-hiv-aids/)
- [All of Us](https://acsr1.com/tag/all-of-us/)
- [NIH Office of AIDS Research](https://acsr1.com/tag/nih-office-of-aids-research/)
- [Cancer disparities](https://acsr1.com/tag/cancer-disparities/)
- [ANCHOR Study](https://acsr1.com/tag/anchor-study/)
- [HSIL](https://acsr1.com/tag/hsil/)
- [Anal Cancer](https://acsr1.com/tag/anal-cancer/)
- [NEJM](https://acsr1.com/tag/nejm/)
- [Joel Palefsky](https://acsr1.com/tag/joel-palefsky/)
- [NHTD](https://acsr1.com/tag/nhtd/)
- [TMA Construction](https://acsr1.com/tag/tma-construction/)
- ["How to"](https://acsr1.com/tag/how-to/)
- [JoVE](https://acsr1.com/tag/jove/)
- [biospecimenscience](https://acsr1.com/tag/biospecimenscience/)
- [biospecimens](https://acsr1.com/tag/biospecimens/)
- [CyTOF](https://acsr1.com/tag/cytof/)
- [antibodies](https://acsr1.com/tag/antibodies/)
- [biochemistry](https://acsr1.com/tag/biochemistry/)
- [cell-surface sugars](https://acsr1.com/tag/cell-surface-sugars/)
- [CD4 T cells](https://acsr1.com/tag/cd4-t-cells/)
- [fucose](https://acsr1.com/tag/fucose/)
- [glycobiology](https://acsr1.com/tag/glycobiology/)
- [HIV/AIDS](https://acsr1.com/tag/hiv-aids/)
- [immunology](https://acsr1.com/tag/immunology/)
- [lectins](https://acsr1.com/tag/lectins/)
- [memory B cell](https://acsr1.com/tag/memory-b-cell/)
- [latent virus](https://acsr1.com/tag/latent-virus/)
- [memory CD4 T cells](https://acsr1.com/tag/memory-cd4-t-cells/)
- [sialic acid](https://acsr1.com/tag/sialic-acid/)
- [single cell analysis](https://acsr1.com/tag/single-cell-analysis/)
- [sugars](https://acsr1.com/tag/sugars/)
- [T cells](https://acsr1.com/tag/t-cells/)
- [EMBLEM](https://acsr1.com/tag/emblem/)
- [Fellowship Opportuniity](https://acsr1.com/tag/fellowship-opportuniity/)
- [Epidemiology](https://acsr1.com/tag/epidemiology/)
- [Enrique Mesri](https://acsr1.com/tag/enrique-mesri/)
- [Argentina HIV Researcher](https://acsr1.com/tag/argentina-hiv-researcher/)
- [Early Investigator](https://acsr1.com/tag/early-investigator/)
- [EIAP](https://acsr1.com/tag/eiap/)
- [New investigator](https://acsr1.com/tag/new-investigator/)
- [NCI Equity Council](https://acsr1.com/tag/nci-equity-council/)
- [Advancement Opportunity](https://acsr1.com/tag/advancement-opportunity/)
- [Early Investigator Advancement Program](https://acsr1.com/tag/early-investigator-advancement-program/)
- [CFAR Adelante](https://acsr1.com/tag/cfar-adelante/)
- [Minority health](https://acsr1.com/tag/minority-health/)
- [HIV Health Disparity](https://acsr1.com/tag/hiv-health-disparity/)
- [HIV Health for Hispanic and/or Latina/x/o](https://acsr1.com/tag/hiv-health-for-hispanic-and-or-latina-x-o/)
- [Cancer Moonshot Scolars](https://acsr1.com/tag/cancer-moonshot-scolars/)
- [UICC](https://acsr1.com/tag/uicc/)
- [World Cancer Congress](https://acsr1.com/tag/world-cancer-congress/)
- [Cervical Cancer](https://acsr1.com/tag/cervical-cancer/)
- [CASCADE](https://acsr1.com/tag/cascade/)
- [Clinical Sites](https://acsr1.com/tag/clinical-sites/)
- [Clinical Trials](https://acsr1.com/tag/clinical-trials/)
- [WAD2022](https://acsr1.com/tag/wad2022/)
- [Germline-targeting](https://acsr1.com/tag/germline-targeting/)
- [neutralizing antibodies](https://acsr1.com/tag/neutralizing-antibodies/)
- [HIV Nef](https://acsr1.com/tag/hiv-nef/)
- [Kaposi's Sarcoma](https://acsr1.com/tag/kaposis-sarcoma/)
- [HIV Transcription](https://acsr1.com/tag/hiv-transcription/)
- [Research highlights](https://acsr1.com/tag/research-highlights/)
- [global health communications](https://acsr1.com/tag/global-health-communications/)
- [ACTHIV](https://acsr1.com/tag/acthiv/)
- [American Conference for the Treatment of HIV](https://acsr1.com/tag/american-conference-for-the-treatment-of-hiv/)
- [HIV Conference](https://acsr1.com/tag/hiv-conference/)
- [End Cancer As We Know It](https://acsr1.com/tag/end-cancer-as-we-know-it/)
- [Close the Care Gap](https://acsr1.com/tag/close-the-care-gap/)
- [National Black HIV/AIDS Awareness Day](https://acsr1.com/tag/national-black-hiv-aids-awareness-day/)
- [HIV/AIDS prevention](https://acsr1.com/tag/hiv-aids-prevention/)
- [HIV stigma](https://acsr1.com/tag/hiv-stigma/)
- [U.S. President's Emergency Plan for AIDS Relief](https://acsr1.com/tag/u-s-presidents-emergency-plan-for-aids-relief/)
- [HIV AIDS Research](https://acsr1.com/tag/hiv-aids-research/)
- [Women and Girls in Science](https://acsr1.com/tag/women-and-girls-in-science/)
- [February 11](https://acsr1.com/tag/february-11/)
- [Structural Racism](https://acsr1.com/tag/structural-racism/)
- [Discrimination](https://acsr1.com/tag/discrimination/)
- [Health Disparities](https://acsr1.com/tag/health-disparities/)
- [nanogels](https://acsr1.com/tag/nanogels/)
- [nanoflorida](https://acsr1.com/tag/nanoflorida/)
- [IWD2023](https://acsr1.com/tag/iwd2023/)
- [Embrace Equity](https://acsr1.com/tag/embrace-equity/)
- [National Women and Girls HIV/AIDS Awareness Day](https://acsr1.com/tag/national-women-and-girls-hiv-aids-awareness-day/)
- [#NWGHAAD](https://acsr1.com/tag/nwghaad/)
- [ASCO 2023](https://acsr1.com/tag/asco-2023/)
- [National Cancer Plan](https://acsr1.com/tag/national-cancer-plan/)
- [#EarthDayEveryDay](https://acsr1.com/tag/earthdayeveryday/)
- [#earthday2023](https://acsr1.com/tag/earthday2023/)
- [#earthday](https://acsr1.com/tag/earthday/)
- [#investinourplanet](https://acsr1.com/tag/investinourplanet/)
- [Notice of Funding Opportunity](https://acsr1.com/tag/notice-of-funding-opportunity/)
- [HPV-OPC](https://acsr1.com/tag/hpv-opc/)
- [human immunodeficiency virus](https://acsr1.com/tag/human-immunodeficiency-virus/)
- [HPV-associated oropharyngeal cancers](https://acsr1.com/tag/hpv-associated-oropharyngeal-cancers/)
- [oral human papillomavirus (HPV) and human immunodeficiency virus (HIV) co-infection](https://acsr1.com/tag/oral-human-papillomavirus-hpv-and-human-immunodeficiency-virus-hiv-co-infection/)
- [Kaposi Sarcoma Herpesvirus Vaccine](https://acsr1.com/tag/kaposi-sarcoma-herpesvirus-vaccine/)
- [HTAN](https://acsr1.com/tag/htan/)
- [Human Tumor Atlas Network](https://acsr1.com/tag/human-tumor-atlas-network/)
- [Cancer Research Data Commons](https://acsr1.com/tag/cancer-research-data-commons/)
- [Cancer Genomics Cloud](https://acsr1.com/tag/cancer-genomics-cloud/)
- [Grants Policy Statement](https://acsr1.com/tag/grants-policy-statement/)
- [NIH-funded grants](https://acsr1.com/tag/nih-funded-grants/)
- [Guidance for Subaward](https://acsr1.com/tag/guidance-for-subaward/)
- [Know your status](https://acsr1.com/tag/know-your-status/)
- [Take the Test & Take the Next Step](https://acsr1.com/tag/take-the-test-take-the-next-step/)
- [Fredericks National Laboratory](https://acsr1.com/tag/fredericks-national-laboratory/)
- [Cancer Care](https://acsr1.com/tag/cancer-care/)
- [Cancer Workforce](https://acsr1.com/tag/cancer-workforce/)
- [Center for Global Health](https://acsr1.com/tag/center-for-global-health/)
- [Satish Gopal](https://acsr1.com/tag/satish-gopal/)
- [Cancer Symposium](https://acsr1.com/tag/cancer-symposium/)
- [Clinical Associated Viral Cancer](https://acsr1.com/tag/clinical-associated-viral-cancer/)
- [Cancer Viruses](https://acsr1.com/tag/cancer-viruses/)
- [UPMC Hillman Cancer Center](https://acsr1.com/tag/upmc-hillman-cancer-center/)
- [Cancer Virology Program](https://acsr1.com/tag/cancer-virology-program/)
- [World Cancer Research Day 2023](https://acsr1.com/tag/world-cancer-research-day-2023/)
- [Cancer Discovery](https://acsr1.com/tag/cancer-discovery/)
- [data science](https://acsr1.com/tag/data-science/)
- [algorithm](https://acsr1.com/tag/algorithm/)
- [cancer screening tool](https://acsr1.com/tag/cancer-screening-tool/)
- [cancer prevention](https://acsr1.com/tag/cancer-prevention/)
- [NOFO](https://acsr1.com/tag/nofo/)
- [ADVANCE](https://acsr1.com/tag/advance/)
- [City of Hope](https://acsr1.com/tag/city-of-hope/)
- [Oncology Symposium](https://acsr1.com/tag/oncology-symposium/)
- [Women's Health](https://acsr1.com/tag/womens-health/)
- [Monica Bertagnolli](https://acsr1.com/tag/monica-bertagnolli/)
- [NIH Director](https://acsr1.com/tag/nih-director/)
- [National Cancer Institute Director](https://acsr1.com/tag/national-cancer-institute-director/)
- [ComboMATCH](https://acsr1.com/tag/combomatch/)
- [research equity](https://acsr1.com/tag/research-equity/)
- [digital pathology](https://acsr1.com/tag/digital-pathology/)
- [proscia](https://acsr1.com/tag/proscia/)
- [concentriq](https://acsr1.com/tag/concentriq/)
- [NCI Director](https://acsr1.com/tag/nci-director/)
- [Dr. Kim Rathmell](https://acsr1.com/tag/dr-kim-rathmell/)
- [Blood Cacner](https://acsr1.com/tag/blood-cacner/)
- [U.S. Department of Health and Human Services (HHS)](https://acsr1.com/tag/u-s-department-of-health-and-human-services-hhs/)
- [Elaine Jaffe](https://acsr1.com/tag/elaine-jaffe/)
- [Robert Yarchoan](https://acsr1.com/tag/robert-yarchoan/)
- [Louis Staudt](https://acsr1.com/tag/louis-staudt/)
- [Journal of Visualized Experiments](https://acsr1.com/tag/journal-of-visualized-experiments/)
- [Macrodissection](https://acsr1.com/tag/macrodissection/)
- [Histochemistry](https://acsr1.com/tag/histochemistry/)
- [Tumor Content](https://acsr1.com/tag/tumor-content/)
- [national cancer month](https://acsr1.com/tag/national-cancer-month/)
- [NIH Strategic Plan](https://acsr1.com/tag/nih-strategic-plan/)
- [HPV screening](https://acsr1.com/tag/hpv-screening/)
- [Last Mile Initiative](https://acsr1.com/tag/last-mile-initiative/)
- [Global research](https://acsr1.com/tag/global-research/)
- [humanitarian Award](https://acsr1.com/tag/humanitarian-award/)
- [HIV prevention](https://acsr1.com/tag/hiv-prevention/)
- [PURPOSE](https://acsr1.com/tag/purpose/)
- [lenacapavir](https://acsr1.com/tag/lenacapavir/)
- [AIDS2024](https://acsr1.com/tag/aids2024/)
- [pre-application webinar](https://acsr1.com/tag/pre-application-webinar/)
- [HIG Stigma](https://acsr1.com/tag/hig-stigma/)
- [Cancer Stigma](https://acsr1.com/tag/cancer-stigma/)
- [DNA](https://acsr1.com/tag/dna/)
- [RNA](https://acsr1.com/tag/rna/)
- [miRNA](https://acsr1.com/tag/mirna/)
- [STAR Protocol](https://acsr1.com/tag/star-protocol/)
- [Cell Press](https://acsr1.com/tag/cell-press/)
- [Specialized Programs of Research Excellence](https://acsr1.com/tag/specialized-programs-of-research-excellence/)
- [SPORE](https://acsr1.com/tag/spore/)
- [Translational Research Program](https://acsr1.com/tag/translational-research-program/)
- [Monica M Bertagnolli](https://acsr1.com/tag/monica-m-bertagnolli/)
- [Dr. W. Kimryn Rathmell](https://acsr1.com/tag/dr-w-kimryn-rathmell/)
- [United by Unique](https://acsr1.com/tag/united-by-unique/)
- [Colon Cancer](https://acsr1.com/tag/colon-cancer/)
- [Colon Cancer Screening](https://acsr1.com/tag/colon-cancer-screening/)
- [Lead From Behind](https://acsr1.com/tag/lead-from-behind/)
- [Colorectal Cancer](https://acsr1.com/tag/colorectal-cancer/)
- [Colonoscopy](https://acsr1.com/tag/colonoscopy/)
- [K99](https://acsr1.com/tag/k99/)
- [R00](https://acsr1.com/tag/r00/)
- [HIV Stigma Day](https://acsr1.com/tag/hiv-stigma-day/)
- [HIV Stigma Warriors](https://acsr1.com/tag/hiv-stigma-warriors/)
- [Biopreservation and Biobanking](https://acsr1.com/tag/biopreservation-and-biobanking/)
- [Latin America](https://acsr1.com/tag/latin-america/)
- [Sao Paolo](https://acsr1.com/tag/sao-paolo/)
- [Brazil](https://acsr1.com/tag/brazil/)
- [Translational Research](https://acsr1.com/tag/translational-research/)
- [Workshop](https://acsr1.com/tag/workshop/)
- [stem cell transplant](https://acsr1.com/tag/stem-cell-transplant/)
- [HIV-HIV resistant gene](https://acsr1.com/tag/hiv-hiv-resistant-gene/)